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The duplication of the genetic material on the complimentary strands of chromosomal 
D N A has imperfections where the 3’ end strand cannot be replicated in its entirety, 
with loss of genetic material. Nature has devised a mechanism to prevent the loss of 
useful information by capping the ends of chromosomes with D N A that carries no 
useful genetic information - the telomeres. Since telomeres are also subjected to loss 
during the same replication process, their lengths are maintained by an enzyme called 
telomerase. 
Recently it has been shown that telomere lengths in peripheral blood mononuclear 
cells were shortened in mothers who were caring for handicapped children compared 
to women with healthy children. This phenomenon correlated with perceived stress. 
The mechanism of perceived stress to telomere shortening was not stated, but one of 
the mechanisms that might be activated under stress is the hypothalamic-pituitary-
adrenal axis (HPA axis) and glucocorticoid secretion. Glucocorticoids are potent 
inhibitors of immune system and may be involved in the regulation of telomere 
lengths. Dexamethasone has been reported to reduce telomerase activity through the 
inhibition of hTERT expression before the induction of apoptosis in human multiple 
myeloma cells in vitro. Intravenous injection of high dose dexamethasone in Balb/c 
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mice (lOOmg/lOg body weight) down-regulated telomerase activity and decreased 
telomere length in thymocyte three hours after injection, before apoptosis ensued. 
W e thus hypothesized that prolonged elevation in serum glucocorticoids in stressed 
individuals may be the reason for telomere lengths shortening or telomerase activity 
down-regulation. To investigate this, 50 Balb/c mice were divided into five groups of 
10 animals each, and given different treatments (stressed, dexamethasone treatment, 
adrenalectomy, vehicle treatment and untreated control). Serum and spleens were 
collected. Corticosterone was assayed by ELISA; telomere lengths of spleen tissue 
were analysed by Southern Blotting; and spleen telomerase activity was detected with 
Telomeric Repeat Amplification Protocol (TRAP) assay. Reverse-transcriptase 
polymerase chain reaction (RT-PCR) targeting m R N A of telomerase reverse-
transcriptase component (mTERT) and Western Blotting towards m T E R T protein 
expression were performed as supplementary evidence in telomerase activity. The 
results show that raised serum corticosterone level in mice stressed for three weeks 
did not correlate with telomere length or telomerase activity regulation. The 
expression of m T E R T niRNA and protein was not affected by serum corticosterone. 
Dexamethasone did not have obvious influence on telomere length, telomerase 
activity, or m T E R T m R N A or protein expression. In conclusion, glucocorticoid 
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1. Literature Review 
1.1 Cell cycle and chromosome replication 
All organisms depend on cell replication for growth and reproduction, which entails 
replication of D N A . Cells in an organism replicate by mitotic division for growth and 
replacement of worn out tissues. Cell division in eiikaryotes has four stages: Gap (G)l 
phase, synthesis (S) phase, G2 phase and mitosis (M) phase. The cell enters the cell 
cycle at early G1 phase. In G1 phase, R N A and protein are synthesized, while D N A is 
not replicated. The cell then passes a restriction point, and is committed to S phase. In 
S phase, along with protein and R N A synthesis, D N A is also replicated, producing 
two copies of chromosomes. After replication of chromosomes, the cell continues to 
synthesize R N A and protein, until the cell size doubles. The cell then enters M phase, 
when the nuclear envelope breaks down, replicated chromosomes divide and two sets 
of chromosomes are pulled to opposite poles of the cell. N e w nuclear envelopes form 
and the cell divides in half; producing two daughter cells. This process repeats itself, 
allowing the organism to grow, replace damaged tissue and reproduce (1). 
When D N A polymerase synthesizes D N A from a starting point, the origin of 
replication, a chromosomal double strand D N A is unwound by the binding of helicase, 
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where ATP or GTP are hydrolysed for energy. This unwinding introduces a torsional 
strain to the coiled DNA. Topoisomerase introduces a negative supercoil by cleaving 
and rejoining the coiled D N A to minimize this strain. Two unpaired strands with 
nucleotide bases exposed result. Primase then cooperates with polymerase a to 
synthesize an R N A - D N A primer of approximately 40 nucleotides in length, including 
about 10 nucleotides of R N A primer. D N A synthesis can be performed with the short 
R N A - D N A serving as a primer by another polymerase for D N A synthesis on either 
the leading strand continuously or for each Olcazaki fragment on the lagging strand 
discontiiuiously (2). Starting with the primer, D N A polymerase produces one copy of 
D N A , starting at 5’end and proceeding to 3' end, adding nucleotides one by one with 
the free 3'-hydroxy 1 group of the primer. After that, D N A polymerase dissociates and 
two sets of D N A are produced after each cycle. However, chromosomes are not 
replicated perfectly during a cell cycle. Since D N A polymerase can only synthesize 
D N A from 5' to 3' direction, an R N A primer is then constructed on the 5' end of the 
D N A templates on the lagging strand, and the D N A synthesis carried out in the 
reverse direction to that of the leading strand. After the lagging strand D N A synthesis 
is completed, the R N A primer, which serves a temporary function in initiating D N A 
synthesis, is hydrolysed. D N A polymerase cannot synthesize the nucleotides occupied 
by the R N A primer, which leaves the replicated D N A a few nucleotides shorter then 
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the template. This is known as ‘end replication problem'. After each round of 
replication, the lagging strand of a chromosome will be shortened, leading to the loss 
of useful genetic information. In order to avoid this, the ends of chromosomes are 
capped with pieces of D N A which contain tandemly repeated sequences, which do not 
contain any useful genetic information. These protective sequences are known as 
telomeres. 
Telomeres of eiikaryotic chromosomes comprise of tandemly repeated guanine (G)-
rich sequences (3, 4). In mammals telomeric sequence T T A G G G is common, while 
the sequence is less stringent (more degenerated) in protozoa and yeast ( T T T T G G G G 
or (TG 1.3)11, for example). It is proposed that this G-rich single-stranded overhang tail 
is folded back and paired with its complement in the duplex portion of the telomere. 
The tract length is different among cell types and chromosome ends, while the size 
range is species specific, varying from 5-30kbp in human and 20-60kbp in mice (5, 6, 
7，8). 
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1.2 Telomere-associated proteins 
The telomeres function in conjugation with a series of telomere-associated proteins 
(table 1). Telomeric-repeat-binding factors (TRFl, TRF2) and protection of telomeres 
1 (POTl) specifically recognize single-stranded telomeric D N A , which bind to it 
directly (9，10, 11). These three proteins belong to a family of oligosaccharide/ 
oligonucleotide-binding (OB) fold-containing proteins, which are highly conserved 
among eukaryotes. However, some telomere-associated proteins do not bind D N A 
directly. These are TRFl-interacting nuclear protein 2 (TIN2), POTl-interacting 
protein (TPPl) and human repressor activator protein (Rapl) (11, 12, 13). TIN2 
though associated with TRFl and TRF2, works in conjunction with TRFl and POTl 
to regulate telomere-length homeostasis (9, 11). Rapl is recruited by TRF2 to 
telomeric region to negatively regulate telomere length in vivo. TPPl recruits POTl 
to telomeres, and is also involved in telomere length regulation. TRFl, TRF2, POTl, 
TIN2, TPPl and Rapl are termed "the telosome" or "Shelterin" (14, 15). 
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Table 1.1. Telomere proteins 
Telomere proteins Description Function 
TERFl(TRFl) Telomeric-repeat-binding factor Controls telomere length (9) 
(NIMA-interacting) 1 
TERF2(TRF2) Telomeric- repeat-binding factor 2 Prevents chromosome ends from 
end-to-end fusions (10) 
RAPl TRF2-interacting telomeric RAPl protein Transcriptional repressor/ 
activator protein, interacts with 
TRF2,(12, 13) 
POTl Protection Of Telomeres 1 Suppresses unwanted DNA 
repair activities by binding to 
single-stranded G-ricli DNA 
overhangs (11). 
丁IN2 TRFl-interacting nuclear protein 2 Coordinates binding of TRFl 
and TRF2, which mediates their 
binding to telomeres (59-67) 
(12, 16-23) 
YPP] homologiie ofciliate telomere binding Form complex with POTl, 
protein-beta (TEBP-beta) increases human telomerase core 
enzyme activity and processivity 
^ 
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1.3 Telomere repair protein 
A series of proteins commonly associated with D N A repair are also involved in the 
repair of telomeres. They are listed in table 2. The M R N complex consists of Meiotic 
recombination 11 homologue A (MREllA), Rad 50 homologiie (RAD50), and 
Nijmegen breakage syndrome 1 (NBSl) (24). The M R N complex is thought to 
process broken D N A ends in preparation for their repair (24). DNA-dependent protein 
kinase (DNA-PK) complex is formed by thyroid autoantigen 70kDa (Ku70), 
antoantigen 86kDa (Ku80), 470kD DNA-dependent protein kinase catalytic subunit 
(DNA-PKcs) (25). DNA-PK is involved in non-homologous end-joining (NHEJ) 
pathway, site-specific recombination of V(D)J gene segments, double strand break 
(DSB) repairs in mammalian systems and assist telomerase function by as yet 
unknown mechanism (26,27). Tankyrase 1/2 binds to TRFl, ataxia telangiectasia 
(ATM) which binds TRF2 (10) and Werner syndrome protein (WRN) block a damage 
response at telomeres (28). 
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Table 1.2. Proteins related to telomere repair 
Telomere repair Description Function 
MREI lA Meiotic recombination 3'-5' exonuclease activity, double-strand 
(Saccharomyces cerevisiae) 11 break (DSB) repair, DNA 
homologue A recombination, maintenance of 
telomere integrity and meiosis (29-31). 
NBSI Nihmegen breakage syndrome 1 Involved in MREI 1/RAD50 
(nibrin) double-strand break repair complex. 
Also involved in DNA double-strand 
break repair and DNA damage-induced 
checkpoint activation (32-34). 
RAD50 Rad50 {S. cerev/5/ae)homologue Forms a complex with MREI 1 and 
NBSl . The protein complex binds to 
DNA and displays numerous enzymatic 
activities that are required for 
nonhomologous ends joining (NHEJ) 
of DNA. This protein, cooperating with 
its partners, is important for DNA 
double- strand break repair, cell cycle 
checkpoint activation, telomere 
maintenance, and meiotic 
recombination (24, 35-36) 
G22Pl(Ku70) Thyroid autoantigen 70kDa (Ku Single stranded DMA-dependent 
antigen) ATP-dependent helicase. The Ku 
XRCC5(Kli80) X-ray repair (doiible-strand-break p70/p86 dimer is probably involved in 
rejoining; Ku autoantigen, 80kDa) stabilizing broken DNA ends and 
bringing them together. They have a 
role in chromosome translocation (25, 
37-40). 
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Table 1.2 (con't). 
Telomere repair Description Function 
PRKDC (DNAPK) Protein kinase, DMA-activated, Serine/threonine-protein kinase that 
catalytic polypeptide (DNA-PKCS) acts as a molecular sensor for DNA 
(DNPKl) damage. May also act as a scaffold 
protein to aid the localization of DNA 
repair proteins to the site of damage, 
regulate other telomeric proteins by 
phosphorylation (25, 41-47). 
TNKS(tankyrase Tankyiase, TRF-1 interacting Regulates binding of TRFl to telomeric 
1/2) ankyrin- related DNA (48-52). 
(ADP-ribose)polymerase 1/2 
W/f^ fv] Werner syndrome Essential for the formation of DNA 
replication focal centers. Exhibits a 
magnesium- dependent ATP-dependent 
DNA-helicase activity. Control of 
genomic stability (46，28) 
ATM Ataxia telangiectasia; involved in Serine/threonine protein kinase which 
signal transduction, cell cycle control activates checkpoint signaling upon 
and DNA repair double strand breaks (DSBs), apoptosis 
and genotoxic stresses such as ionizing 
ultraviolet A light (UVA), thereby 
acting as a DNA damage sensor 
(53-55). 
ADPRT(PARP) ADP-ribosyltransferase Involved in the base excision repair 
[NAD+;poly(ADP-ribose) (BER) pathway, by catalyzing the poly 
polymerase] (ADP- ribosyl) ation of a limited 
number of acceptor proteins involved in 
chromatin architecture and in DNA 
metabolism (56-59). 
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1.4 Function of telomere 
The major function of the telomere is to "cap" the ends of chromosome. The 
end-capping of chromosomes can prevent them from joining each other through 
fusion of chromosomal ends, thus resulting in recombination and mutation (3-4，60). 
Degradation of damaged chromosomes is also possible without the protection of 
telomere (60). The capped telomere will not be recognized as double strand breaks 
(DSBs), and stop the D N A repair mechanisms in the cell from treating D N A ends as 
damage. Otherwise, the broken ends initiate apoptosis mechanisms by p56 and 
pl^iNK4a pathways to eliminate cells having aberrant chromosomes (61). The capping 
also prevents telomerase from extending the telomeric sequence (3-4). 
Once a telomere has shortened beyond a critical length, a cell stops its replicative 
activity, resulting in cellular senescence. This is known as mortality stage 1 (Ml). 
This stage can be bypassed by the expression of helicase which allows a cell to 
continue dividing. If a telomere continues to shorten, it enters mortality stage 2 (M2), 
characterized by end-to-end fusions of chromosomes, detachment of the telomeres 
from the nuclear matrix and large scale apoptosis (62). 
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1.5 Telomerase 
Telomerase is an RNA-dependent D N A polymerase, which adds telomeric sequences 
to an end of a chromosome (3-4，60). It is expressed in nucleus. It consists of an R N A 
component and several protein components, listed in table 3. The two major 
components essential for telomerase activity are R N A (liTR) and reverse-transcriptase 
(TERT) components (63-65). The hTR component is a molecule of R N A about 150 
nucleotides long, containing about 1.5 copies of the appropriate complementary 
cytosine-adenine (CA)-rich telomere repeat, acting as the template sequence. On the 
other hand, TERT is a protein consisting of 1131 amino acids. T E R T component can 
lengthen the telomere on the 3'-end and proceeds in the usual 5' to 3' direction with 
its D N A synthetic activity (66). After synthesis of one copy of the repeat, the enzyme 
repositions to the end of newly synthesized telomeric sequence and the synthesis is 
repeated, thus further extending the telomere. The expression of TERT component in 
mouse (mTERT) may contribute to resistance to apoptosis (67). 
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Current studies show that 85% of the immortalized cell lines have telomerase activity 
(68). Several publications have shown that telomerase activity is detected for those 
cells after crisis, in which telomere length is shortened to minimal. The telomerase 
activity is critical in stabilizing and preventing telomere loss (66，69-70). Also, the 
expression of telomerase can immortalize a cell line (69). Moreover, there is evidence 
suggesting that telomerase is involved in cellular differentiation and death (65, 67). 
11 
Table 1.3. Telomerase components 
Telomerase Description Function 
component 
TERT (liTERT) Telomerase reverse transcriptase Ribonucleoprotein enzyme essential for 
the replication of chromosome termini. It 
is a reverse transcriptase that adds simple 
sequence repeats to chromosome ends, 
telomeres, by copying a template 
sequence within the RNA component of 
the enzyme (60, 70). 
TERC (hTR) Telomerease RNA component RNA template for telomerase to elongate 
telomere 60, 70-71) 
HSPCA (HSP90) Heat shock 90 kDa protein 1 ’ molecular chaperones (72) 
alpha 
P23 Telomerase-binding protein, p23 Molecular chaperone that localizes to 
genomic response elements in a hormone-
dependent manner and disrupts receptor-
mediated transcriptional activation, by 
promoting disassembly of transcriptional 
regulatory complexes (73). 
TEPl (TP l ) Telomerase-associated protein 1 A component of the ribonucleoprotein 
complex responsible for telomerase 
activity (72) 
SSB (La) Sjogren syndrome antigen B involved in binding and protecting 
(aiitoantigen La) 3-prime UUU(OH) elements of newly 
RNA polymerase III -transcribed RNA, 
processing 5-prime and 3-prime ends of 
pre-tRNA precursors and acting as an 
RNA chaperone (75-77) 
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Table 1.3 (con't). 
Telomerase Description Function 
component 
RPL22 (L22) Ribosomal protein L22 Component of ribosomal protein which 
synthesizes protein (78，79) 
STAU Staufen (Drosophila RNA-binding Binds double-stranded RNA (regardless 
protein) of the sequence) and tubulin. Stimulates 
translation of RNA at binding site 
(80-81). 
DKCI Dyskeratosis congenita 1, dyskerin A member of the H/ACA small nucleolar 
riboniicleoproteins (snoRNPs) gene 
family, and are involved in various 
aspects of rRNA processing (82-84) 
NOLAl ( G A R l ) Nucleolar protein family A, H/ACA snoRNPs, form telomerase 
member 1 (H/ACA small nucleolar complex with the DKCI, N 0 L A 2 and 
riboniicleoproteins) N 0 L A 3 proteins. Involved in various 
aspects of rRNA processing and 
modification (85-87). 
13 
1.6 Factors affecting telomere length 
Telomere length can be either decreased or increased by several factors. Natural 
chromosomal replication decreases telomere length because of "end replication 
problem". After each round of D N A replication, part of the telomere is not replicated 
(88), which would eventually lead to a complete loss of telomere, if telomere 
maintenance mechanisms were not turned on. Also, overexpression of telomeric-
repeat binding factor, TRFl and TRF2 are also found to shorten telomere length. They 
do not detectably affect the expression of telomerase and they inhibit the action of 
telomerase at the ends of individual telomeres (9, 10, 61). Oxidative stress, stem cell 
transplant and chemotherapy also play a role in decreasing telomere length. 
On the other hand, telomerase increases telomere length. Also, alternative lengthening 
of telomere (ALT) pathways lengthen telomere without the involvement of telomerase. 
ALT pathways are mostly recombination of telomeric sequences and the resulting 
telomere is relatively unstable compared to those made by telomerase (89). 
1.7 Stress and telomere length 
In a recent study by Epel and co-workers (90), it was found that the telomere length in 
peripheral blood mononuclear cells (PBMC) of mothers who were caring for 
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chronically sick children were shorter than those of women who had cared for healthy 
children. Based on a questionnaire that was designed to assess the stress level in the 
study groups, the women looking after sick children were found to be under higher 
self-reported psychological stress. Therefore it appears that psychological stress, 
which affects health and modulates rate of cellular aging, also has an impact on 
telomere length. Moreover, psychological stress has been reported to down-regulate 
the messenger R N A expression of protooncogenes，such as c-Myc (91), which 
induces TERT gene expression in primary human fibroblasts, thus influencing 
telomerase activity (92). This stabilizes telomere lengths. On the other hand, it is 
known that oxidative stress is associated with shorter telomere length (90，93). G-rich 
telomeric repeats are highly sensitive to damage by oxidative stress, alkylation or 
ultraviolet (UV) irradiation (93). Oxidative stress is a disturbance in the balance 
between the production of reactiv oxygen species and antioxidant defenses, which 
leads to double-stranded breaks in chromosomes (94). Oxidative damage is repaired 
less well in telomeric D N A compared to the rest of the chromosome, thus resulting in 
accelerated telomere shortening and chromosomal instability (95-96) 
15 
1.8 Definition of Stress 
Human beings detect the external environment by perceptions: vision, hearing, smell 
and touch. The cerebrum receives signals from these senses, integrate them, and reacts 
according to the interpretation. Pleasure or dysphoria can be associated with stress, 
termed eustress or distress respectively. If one individual interprets a stressful 
situation, either pleasure or dysphoria, the protective system 一 a stress response would 
be triggered (97). Stress, defined by Selye, is "result of any demand upon the body" 
(98) and composes of three components: stimulus, response and transactional (99). 
Stimulus is defined as an influence which tenses up the body, making one feel anxious 
and disrupts homeostasis. The source can originate from internal feelings such as guilt, 
worries and unfulfilled expectations; or from external stimulations such as danger. 
Response is defined as internal feelings caused by external stimulations. The 
examples of those feelings are tension or anxiety. The key point of this definition 
focuses on the perturbation of the cognitive status of the individual. Transactional is 
defined as some measurable, predictable and reproducible biological effects after 
exposure to a stress stimulus, such as responses in heart rate, blood pressure, 
hormones alterations in immune system. Stimulation and corresponding predictable 
response should be present in order to fulfill the definition of transactional stress 
(100). 
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1.9 Central nervous system components involved in stress response 
When a stimulus is perceived, the stress system, involving central nervous system 
(CNS) and some peripheral components, will be triggered. There are four central 
components for the stress system, including: i) the parvocellular neurons which secret 
corticotropin-releasing hormone (CRH); ii) the paraventricular nuclei (PVN) of the 
hypothalamus, consisting of the arginine vasopressin (AVP) neurons; iii) the 
paragigantocelliilar and parabraiichial nuclei of the medulla and the locus ceruleus 
(LC), neurons that secret CRM; and iv) cells in the medulla and pons, which are 
mostly noradrenergic (NE) cells (LC/NE system) (101-102). Moreover, the peripheral 
components of the stress system include i) the peripheral limbs of the hypothalamic-
pituitary-adrenal (HPA) axis; ii) the efferent sympathetic-adrenomedullary system; 
and iii) components of the parasympathetic system. There are multiple sites of 
interaction among the various components of the stress system. Stress will stimulate 
the stress centres mentioned above, triggering a series of physiological reactions (99). 
1.10 Glucocorticoid 
Glucocorticoid is the final product of HPA axis (103). When this axis is triggered, 
C R M is secreted by the hypothalamus, follows by adrenocorticotropic hormone 
(ACTH) from the anterior pituitary, and finally Cortisol in human beings or 
17 
corticosterone in rodents. AVP is a potent synergistic factor of CRM. Each 
neuropeptide stimulates the secretion of the other at the level of hypothalamus. Both 
C R H and AVP are secreted in the portal system in a circadian, pulsatile and highly 
concordant fashion under non-stressful situations. Under stressful conditions, the 
amplitude of paraventricular nuclei C R H and AVP pulsatile release into the 
hypophyseal portal system is increased (104-107). Also, angiotensin II, various 
cytokines and lipid mediators of inflammation are secreted and interact at 
hypothalamic, pituitary and/or adrenal level, altering their activity. The adrenal cortex 
is the main target of ACTH. Glucocorticoid secretion is controlled by the interaction 
of A C T H and zona fasciculata and reticularis regions of adrenal cortex in adrenal 
gland. Cytokines and autonomic nerves of the adrenal cortex are also involved in the 
regulation of Cortisol secretion (107-109). 
Glucocorticoid is a collective name of a family of steroid hormones, which regulates 
body homeostasis, and helps us to cope with stressful conditions (101, 103). Their 
effects are mediated through their ubiquitously distributed intracellular glucocorticoid 
receptors (GR) (110). When a G R is bound by a glucocorticoid, the receptor 
dissociates from hsp90 and translocates to the nucleus, and binds as a homodimer to 
glucocorticoid-response elements (GREs) located in the promoter region of target 
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genes, which either up-regiilate or down-regulate gliicocorticoid-responsive genes. 
The regulation depends on the G R E sequence and the context of the promoter. 
Glucocorticoids are vital in the regulation of the H P A axis. Also, they are important in 
the termination of the stress response by negative feedback to the extrahypothalamic 
centres, the hypothalamus and the pituitary gland. Therefore, the catabolic, lipogenic, 
anti-reproductive and immunosuppressive effects of glucocorticoids can be minimized 
by limiting the secretion of C R M and A C T H , which limits the exposure time of target 
organs to glucocorticoid (103，111). 
The glucocorticoids involved in H P A axis are different in different species of animal. 
In human, Cortisol is secreted as final product of the H P A axis. In mice, the 
microsomal 17 hydroxylase (P450cl7) necessary for Cortisol synthesis is lacking. 
Therefore，corticosterone is secreted by the adrenal gland instead. 
1.11 Physiological effects under the activation of stress system 
In normal circumstances, the secretion of glucocorticoid follows a circadian rhythm 
with peak levels occurring in the morning and nadir at midnight (112). When an 
animal is stimulated under a stressful event such an impending attack by a predator, 
besides a surge of adrenaline (a fight and flight hormone), there is also a surge of 
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glucocorticoids. The activation may be due to neurosensory, blood-borne and limbic 
signals. When the stress system is activated, a series of physiological effects occur, 
such as heightened arousal, accelerated motor reflexes, improved attention and 
cognitive function, decreased appetite and sexual arousal, and increased tolerance to 
pain. Cardiovascular function and intermediary metabolism would be altered, and 
immune-mediated inflammation would be suppressed. All of these changes prepare an 
organism for coping with the stressful situations (103). 
1.12 Effects of chronic hyperactivation of the stress system 
When the stress system is activated for a short period of time, the anti-growth, 
anti-reproductive, catabolic and immunosuppressive effects can be beneficial to the 
body ill order to cope with the adverse condition (97，113). However, prolonged 
activation of the stress system may result in a number of disorders in a body. The 
growth axis is inhibited by hormones secreted by the I-IPA axis at various levels 
(114-115). Prolonged activation of the H P A axis inhibits growth hormone (GH) 
secretion, suppresses the effects of insulin-like growth factor I (IGF-I) and other 
growth factors (116). 
The reproductive axis is also inhibited at all levels by hormones secreted in H P A axis 
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(117-118). C R M stimulates the arcuate proopiomelanocortin (POMC) peptide-
secreting neurons, thus suppressing gonadotropiii-releasing hormone (GnRH) 
secretion. Glucocorticoids inhibit the action of G n R H neuron, the pituitary 
gonadotroph and the gonads and alter the effect of gonadal steroids on their target 
tissues. Elevated cytokines concentrations during inflammatory stress may also 
suppress reproductive function, involving inhibition of both G n R H pulsatile secretion 
from the hypothalamus and ovariaii/testiciilar steroidogenesis (117，118). 
Moreover, fat tissue catabolism (lipolysis) and muscle and bone anabolism due to 
actions of G H and sex steroids are antagonized by glucocorticoids (119). Decrease in 
lean body mass (bone and muscle mass), increase in visceral adiposity and 
suppression of osteoblastic activity are related to chronic activation of stress system. 
Patients with increased H P A axis activity, such as Cushing's syndrome, melancholic 
depression and patients with the metabolic syndrome (visceral obesity, insulin 
resistance, dyslipidemia, atherosclerotic cardiovascular disease, hypercoagulation, 
hypertension and sleep apnea) also show similar manifestations (120-121). 
Immune response is found to be inhibited under the effect of prolonged activation of 
H P A axis (100, 122-123). Glucocorticoids are well-known immunosuppressant, 
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suppressing the production of cytokines and inflammation mediators. They also 
inhibit the action of inflammation mediators on target tissues. Several immune factors 
show a circadian rhythm in concentration in reverse-phase synchrony with respect to 
plasma glucocorticoid concentration (124). Prolonged increase in plasma 
glucocorticoid level suppresses mostly innate and cellular immunity, leads to 
infections (common cold, tuberculosis), and neoplastic diseases which are related to 
deficiency of immune responses mentioned above (125). Glucocorticoids also induce 
G1 cell cycle arrest (126), apoptosis of immature thymocytes (127), pre-B lymphoma 
cells (128)，mature peripheral T lymphocytes (129-130), and several leukemic cell 
lines (129,131). Also, glucocorticoids redirect leukocyte traffic and function, ensuring 
that appropriate leukocytes are present in the right place at the right time for the 
response of immune challenge. When plasma corlicosterone level increases due to 
exposure to stressful stimuli, numbers and percentages of lymphocytes decrease 
significantly while numbers and percentages of neutrophils increases in the blood 
(132-133). Other immune cells such as peripheral blood helper T cells, cytolytic T 
cells, B cells, natural killer cells and monocytes decrease in absolute number 
significantly during stress (134). Neutrophils, monocytes and B cells in the body 
gradually redistribute, leaving peripheral blood and enter the spleen, resulting in 
spleen enlargement (135-137). 
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1.13 Hypothesis 
An individual under prolonged physiological or psychological stress shows an 
elevated level of glucocorticoid secretion, thus having a series of physiological 
manifestations. Prolonged physiological or psychological stress is also associated to 
telomere shortening and decreased telomerase activity. In this study, we hypothesize 
that corticosteroid exposure is related to telomere length regulation or telomerase 
activity regulation. 
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2. Materials and Methods 
2.1 Materials 
Dexamethasone was obtained from United States Biochemicals Co. (Cleveland, Ohio, 
USA). Salmon sperm DNA, D N A restriction enzymes Hinfl and Rsal were obtained 
from Invitrogen (Carlsbad, California, USA). Proteinase K was obtained from Sigma -
Aldrich (St. Louis, M O , USA). Positively charged nylon membrane, DIG III marker, 
0.125-21.2 kbp, DIG VII marker, 0.081-8.57 kbp, sheep anti-DIG antibody - alkaline 
phosphate conjugate (Anti-DIG-AP), disodiiim 3-(4- methoxyspiro [1,2- dioxetane-
3,2'-(5'-chloro)- tricyclo [3.3.1.13,7] decan]-4-yl) phenyl phosphate (CSPD) and DIG 
Wash and Block buffer set were obtained from Roche Applied Science (Basel, 
Switzerland). Protein Assay Dye Reagent Concentrate, polyvinylidene fluoride 
(PVDF) membrane, Mini Protean II electrophoresis cell and the respective 
electroblotting accessories were obtained from Bio-Rad Laboratories Inc. (Hercules, 
CA, USA), Anti-TERT and anti-histone antibodies were obtained from Santa Cruz 
Biotechnology Inc. (Santa Cruz, CA, USA). Horseradish peroxidase (HRP) 
conjugated goat anti-rabbit IgG and ECL Advance Western Blotting Detection Kit 
were obtained from Amersham Biosciences (Piscataway, NJ, USA). Corticosterone 
ELISA kit was obtained from D R G Instruments (Marbiirg/Lahn, Germany). 
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Quantitative Telomerase Detection (QTD) kit was obtained from US Biomax Inc. 
(Rockville, M D , USA). RNeasy total R N A extraction kit was obtained from Q I A G E N 
(HiMen, Germany). Access RT-PCR System was obtained from Promega (Madison, 
WI, USA). Synthetic oligonucleotides used in polymerase chain reaction were 
obtained from Operon (Cologne, Germany). They were forward primer mTERT658F 
(5'-AGATCAAGAGCAGTAGTCGCCAG-3'), the reverse primer mTERT950R 
(5'-TTTACAGCACACCGACCCAGAG-3') (63), internal control forward primer 
L19F (5'-GAAATCGCCAATGCCAACTC-3') and reverse primer L19R 
(5'-TCTTAGACCTGCGAGCCTCA-3') (138). All other chemicals were reagent 
grade compounds obtained from British Drug House Chemical Ltd. (BDH, Poole, 
UK), Merck (Darstadt, Germany), Sigma-AIdrich (St. Louis, M O , USA), and other 
commercial sources. 
2.2 Experiment animals 
Fifty Balb/c male mice 6-8weeks of age were used as the animal model in this study. 
The mice were obtained from Laboratory Animal Service Centre (LASEC), C U H K . 
The project had been approved by the Clinical Research Ethics Committee of the 
Chinese University of Hong Kong (Ethics approval: 05/051/ERG). The animals were 
divided into 5 groups of 10 mice each. The groups were: i) Unstressed control group, 
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ii) Physically stressed group, iii) Dexamethasone treated group, iv) Vehicle treated 
group, V) Adrenalectomized group. 
2.3 Methods 
2.3.1 Treatment schedule 
Mice in each group were weighed every two days. All mice had access to food and 
water ad libidim. The animals in the unstressed control group were not disturbed, 
except for routine handling, which included weighing, feeding and changing bedding. 
The physically stressed mice were subjected to rotary shaking on an orbital shaker 
everyday during their active period from 2200 to 0600 at 50 rotations per minute 
(rpm). They had access to food and water during the administration of stress. The 
dexamethasone treated mice were injected with 1 jiig of dexamethasone in 0.1 ml 
peanut oil as vehicle. The vehicle treated mice were injected with 0.1 ml peanut oil. 
Injections for both dexamethasone and vehicle treated groups were carried out once 
every four days during the treatment period. The adrenalectomized group had their 
adrenal glands removed by a veterinarian at L A S E C before the treatment period 
started. They were not disturbed except for routine handling. Since the animals had 
their adrenal glands removed, the animals cannot secrete aldosterone, which is the key 
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hormone in controlling sodium ion homeostasis (139). Thus they were provided with 
0.9% saline instead of tap water for their drinking need. The treatment period for all 
mice lasted three weeks. 
2.3.2 Organ extraction and serum preparation 
After the treatment period, the animals were weighed, stunned, and blood was 
removed by cardiac puncture. Between 800 |_d to 1 ml of blood could be obtained 
from each mouse. The blood was allowed to clot, centrifuged at 1300 g in a 
microcentrifuge (Eppendorf AG, Hamburg, Germany) at 4'^ C for 10 min. Serum was 
collected and stored in 1.5 ml microfuge tube at -20°C. After exsangiiination the mice 
were sacrificed by cervical dislocation. The mice were dissected and their spleens and 
adrenal glands were removed, weighed and stored at -80°C. 
2.4 Serum corticosteroid assay 
Serum corticosterone was assayed by an enzyme-linked immunosorbent assay 
(ELISA), which is based on the principle of competitive binding. Briefly, 
corticosterone in mouse serum sample competes with corticosterone-horseradish 
peroxidase conjugate for binding sites on the coated antibody. After Ihr incubation, 
the unbound conjugate is washed off. The amount of peroxidase conjugate bound is 
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inversely proportional to the concentration of corticosterone in the sample. After the 
addition of the tetramethylbenzidine (TMB) substrate solution, this reacts with 
peroxidase to generate a yellow coloured product that can be measured at 450 nm 
using a standard spectrophotometer. The intensity of colour developed is inversely 
proportional to the concentration of corticosterone in the serum sample. 
Each assay for samples and coticosterone standards was done in duplicate. The 
desired number of anti-corticosterone antibody coated wells was mounted in the 
holder provided by the kit manufacturer. A pilot assay was carried out to determine 
whether the corticosterone concentration in samples exceeded the maximum standard 
value. Serum samples were diluted if their concentration exceeded the maximum 
standard. The pilot study showed that corticosterone concentrations in serum samples 
fall within the range of standards. Twenty microliters of each standard and undiluted 
sample were pipetted into labeled wells. Corticosterone enzyme conjugate was diluted 
1:250 with the diluent supplied with kit, and 200 |al was added to each well. The 
whole plate was shaken for 10 sec in a plate shaker to ensure thorough mixing, and 
the plate was incubated at room temperature for 60 min. During the incubation time, 
wash solution was prepared by diluting 30 ml of the concentrated wash solution 
supplied in kit with 1170 ml autoclaved Milli-Q water to a final volume of 1200 ml. 
28 
After incubation, the contents of the wells were gently removed by inverting the plate 
over a sink, followed by gently tapping the plate on a paper towel. The wells were 
rinsed three times with 400 |il of diluted wash solution. The rinse solution was 
removed by inverting the plate over a sink, followed by a sharp tap on an absorbent 
paper to remove any adhering droplets. After the last rinse, 100 )il of substrate 
solution was added to each well and the plate was incubated at room temperature for 
15 min. The reaction was stopped by adding 50 |.il of 0.5 M H2SO4 stop solution to 
each well. Absorbance at 450 nm was measured in a microtiter plate reader (Victor3 
Multilabel Counter, PerkinElmer, M A , USA) within 10 min after the addition of stop 
solution. From the absorbance readings, averages for duplicates were calculated. A 
standard curve showing the mean absorbance values of each standard against their 
corresponding concentrations was plotted with Excel software (Microsoft Corp, 
Redmond, W A , USA). The equation for the standard curve was obtained, and sample 
concentrations were calculated from the equation. 
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2.5 Telomere length assay 
2.5.1 Genomic DNA extraction 
A piece of spleen tissue weighing about 30 m g from each animal in the study was put 
in 2 ml TE buffer (10 m M Tris-HCl, 1 m M EDTA, pH 7.5) and 5 of 10 mg/ml 
proteinase K added to each tube. The mixture was incubated in a 60°C water bath 
overnight for digestion of tissue protein. After digestion, 600 |al 6 M NaCl was added, 
vortexed vigorously for 10 sec and centrifuged at 3000 rpm at 4°C for 10 min. The 
supernatant was then decanted into a clean test tube, and 1.3 ml of phenol-
chloroform-isoamyl alcohol (25:24:1 v/v) added. The contents were vortexed for 10 
sec. The mixture was centrifuged at 3000 rpm at 4°C for 10 min. The upper aqueous 
layer was transferred to a clean test tube and 2 ml of chloroform was added and 
vortexed for 10 sec. The mixture was centrifuged at 3000 rpm at 4°C for 10 min and 
the upper aqueous layer was transferred to a clean test tube. Five milliliters of ice cold 
absolute alcohol (BDH-Merck Ltd., Poole, U K ) was added to precipitate D N A . The 
precipitated D N A was transferred to a 1.5 ml microcentrifuge tube and washed with 1 
ml 70% alcohol, prepared by diluting absolute alcohol with autoclaved Milli-Q water. 
The D N A was pelleted by centrifugation at 3000 rpm at 4°C for 10 min. The alcohol 
fraction was discarded and the D N A pellet was allowed to dry on benchtop overnight. 
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The pellet was dissolved in 400 )il aiitoclaved Milli-Q water. 
Genomic D N A absorbance was measured at 260 nm using a spectrophotometer 
(Nanodrop, Wilmington, DE, USA) and concentration was calculated using the 
following formula: 
DNA in jAg/ml = (OD26(MO) ^dilution factor 
Genomic D N A samples were kept at 4®C for further investigations. 
2.5.2 Genomic DNA digestion 
Twenty microgram of genomic D N A extracted from mice spleen tissues were digested 
with 5 U each of Hinfl and Rsal endonuclease, in buffer containing 50 m M Tris-HCl 
(pH 8.0), 10 m M M g C b and 25 m M NaCl as supplied by the manufacturer of 
restriction enzymes. Hinfl recognizes subtelomeric site to incise telomeric D N A from 
genomic D N A , while Rsal digests non-telomeric D N A into smaller fragments 
(restriction site of Hinfl and Rsal are shown in Figure 2.1 and Figure 2.2 respectively). 
The mixture was incubated at 37®C for 12 hr. Four microliters of 6X D N A gel loading 
buffer was added to stop the enzymatic reaction. 
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Figure 2.1. Restriction site of Hinfl 
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Figure 2.2. Restriction site of Rsal 
2.5.3 Southern blotting procedure 
The digestion product was separated by agarose gel electrophoresis. The 0.8% 
agarose gel was prepared by heating 0.56 g agarose in 70 ml IX T A E buffer (40 m M 
Trizma base, 20 m M glacial acetic acid, 1 m M EDTA) in microwave oven until 
completely dissolved. The gel was poured in a mould with a well comb and allowed 
to set on a benchtop. After the gel had set, it was submerged in IX T A E as 
electrophoresis buffer. Twenty microliters digested D N A samples were loaded into 
each sample well of the agarose gel. Two microliters of DIG- labelled D N A molecular 
weight markers (1 DIG III marker, 0.125 - 21.2 kbp and 1 |.il DIG VII marker, 
0.081 - 8.57 kbp) with 2 …2X gel loading buffer (5% (v/v) glycerol, 0.083% (w/v) 
bromophenol blue, 80 m M Trizma base, 40 m M glacial acetic acid, 2 m M EDTA) 
were loaded in the wells at extreme ends. The gel was run at 90 V for 3 hr, for the 
separation of D N A fragments according to their sizes. 
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For depurination of the D N A fragments, the gel was soaked in 0.25 M HCl solution 
for 10 min at room temperature with gentle agitation. The gel was rinsed with 
autoclaved Milli-Q water two times, and then submerged with gentle agitation in the 
denatiiration solution for 15 min at room temperature. The cycle was repeated once 
more. The gel was rinsed briefly with autoclaved Milli-Q water two times. The same 
cycle was repeated twice again, but this time with neutralising solution (0.5 M Trizma 
base, 3 M Sodium chloride, pH 7.5). 
The separated D N A fragments in the gel were transferred onto nylon membrane by 
capillary transfer. A transfer setup is illustrated in figure 2.3. 
Z weight 
一- g lass plate 
u z - z - z , , 
paper towels \ 50。9 一 
nitrocellulose fil ler � \ \ 室 Whatman 3 M M paper 
or nylon m e m b r a n e � � � \ = z , 
\ z , z g 引 
Whatman 3MM p a p e r � � \ � ‘ z一一 
t ransfer buffer ��� \ — 
:•一 -- Ikmm 
Figure 2.3. Transfer setup in Southern Blotting. 
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A nylon membrane was cut to the same size as the agarose gel, i.e. 9 cm xl 1 cm. 
The membrane was wetted with autoclaved Milli-Q water and equilibrated in 20X 
SSC buffer (3 M Sodium chloride, 0.3 M Sodium citrate) for at least 5 min. The gel 
was placed on top of Whatman 3 M M paper on a solid support, with parafilm sealing 
the four edges of the gel to avoid short circuit of the transfer buffer between the gel 
and the nylon membrane. The nylon membrane was placed immediately on top of the 
agarose gel. Two pieces of Whatman 3 M M paper, 9 cm x 11 cm, were placed on top 
of the membrane. A pile of dry absorbent paper was place on top of Whatman 3 M M 
paper to create and maintain capillary action to draw 20X SSC transfer buffer through 
the gel. The process caused D N A fragments to transfer to the nylon membrane with 
the buffer current. Close contact between layers of materials used in the setup was 
maintained by placing a 500 g weight on top of the paper towel. The transfer was 
allowed to operate overnight to facilitate complete transfer of D N A fragments. After 
that, the membrane was washed with 2X SSC (0.3 M Sodium chloride, 0.03 M 
Sodium citrate) for 5 min, and it was baked at 120*^ 0 for 20min to fix the transferred 
D N A . After baking, the membrane was washed with 2X SSC. The wet membrane was 
now ready for hybridization. The nylon membrane with transferred D N A was placed 
in a hybridization bottle with D N A side facing inward, and 5 ml prewarmed (45°C) 
hybridization solution was added. The bottle was rotated in a hybridization oven at 
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for Ihr as prehybridization. Then 2 of DIG-labeled telomere probe 
(AATCCC)4 was added to the 5 ml hybridization solution in the bottle. The bottle was 
placed back in the oven, and hybridization allowed to continue at 45°C for 3 hr. Next 
the membrane was washed twice with 5 ml stringent wash buffer I (2X SSC, 0.1% 
Tween-20) in the bottle, with 5 min rotation on a roller at room temperature. The 
membrane was then washed twice with prewarmed stringent wash buffer II (0.2X 
SSC, 0.1% Tween-20) for 15 min at 50°C in a hybridization oven with rotation. 
After that, the membrane was washed with 20 ml IX wash buffer in the wash and 
block buffer kit (Roche Applied Science, Basel, Switzerland) for 5 min at room 
temperature with gentle agitation. The membrane was incubated in 30 ml freshly 
prepared IX blocking solution (Roche Applied Science, Basel, Switzerland). Three 
microliters of sheep anti-digoxigenin antibody conjugated to alkaline phosphatase 
(sheep anti-DIG-AP) was diluted 1:10000 with 30 ml blocking buffer, and the 
membrane was incubated in this solution for 30 min at room temperature with gentle 
agitation. The membrane was washed two times for 15 min with 15 ml IX wash 
buffer. The washed membrane was equilibrated in 20 ml IX detection buffer for 5 min 
at room temperature with gentle agitation. The membrane was placed in a 
hybridization bag, and diluted CSPD substrate (prepared by diluting 5 [i\ of CSPD 
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(disodium 3-(4-methoxyspiro [1, 2- dioxetane-3, 2'- (5'-chloro) - tricyclo [3.3.1.13, 7] 
decan]-4-yl) phenyl phosphate) solution with 500 |.il IX detection buffer) was 
dispensed on the membrane evenly. The membrane was incubated at room 
temperature for 5 min, covered with aluminum foil. After that, the membrane was 
incubated at 37"C for 15 min for signal enhancement. Excess substrate solution was 
absorbed with tissue paper, and the membrane was exposed to X-ray film in a film 
cassette (Kodak Co., Rochester, NY, USA) for one hour for signal to appear. 
The bands of telomere fragments were analysed by densitometer. Briefly, light from 
the light box of the densitometer passes through X-ray film, and the transmittance of 
bands is detected by scanner and calculated by Quantity One software (Bio-Rad 
Laboratories, Inc., Hercules, CA, USA) to give band densities. Telomere length is 
calculated by the following formula: 
一 :(〇Di) 
TRF 二 
s ( O D / g 
ODj is the chemiluminescent signal and Lj is the length of the TRF fragments at 
position i. 
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2.6 Telomeric Repeat Amplification Protocol (TRAP) assay 
A commercial kit was purchased from US Biomax (MT3010, US Biomax, Inc., 
Rockville, M D , USA). Materials necessary for the reaction were provided in the kit. 
It contained lysis buffer for telomerase extraction from tissue samples, telomerase 
substrate (TS) oligonucleotide, reverse primer, internal control for real-time 
polymerase chain reaction (PGR) reaction of T R A P assay and S Y B R green dye which 
binds specifically to double-stranded D N A minor groove to give a fluorescence signal. 
Telomerase in sample extract elongates TS oligonucleotide in a reaction mixture. The 
elongated TS then acts as templates in PGR. During annealing steps in the PGR, 
S Y B R green dye binds with PGR products which are double-stranded D N A present in 
reaction mixture, producing a fluorescent signal. The signal intensity is directly 
proportional to the concentration of double-stranded DNA. If there are more starting 
template oligonucleotides present in a reaction mixture, more P G R product will be 
produced, and a significant rise in fluorescent signal from background can be detected 
during earlier PGR cycles. This signifies that more elongated TS is present in the 
reaction mixture, i.e. higher telomerase activity. Signal intensity is measured by the 
fluorescence detector in a real-time PGR machine. A fluorescence threshold cycle (Cj) 
number is the number of cycle at which significant rise in fluorescence signal is 
detected. Smaller Cj number represents higher telomerase activity. 
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2.6.1 Extract preparation and protein concentration quantitation 
To prepare tissue extract for telomerase reaction detection, a tissue slice weighing 
about 30 m g was resuspended in 200 pi IX lysis buffer provided in the kit and 
homogenized with a hand-held pestle fitted with 1.5 ml microcentrifuge tube. The 
homogenate was incubated on ice for 30 min and then centrifuged in microcentrifuge 
at 12000 g for 30 min at 4。C. One hundred and sixty microliters of supernatant was 
transferred to a fresh labeled 1.5 ml microcentrifuge tube and protein concentration 
was determined by Bradford assay. Protein Assay Dye Reagent Concentrate was used 
to determine protein concentration. The Coomassie blue dye binds primarily to basic 
and aromatic amino acid residues, especially arginine (140). The absorbance 
maximum for an acidic solution of Coomassie® Brilliant Blue G-250 dye shifts from 
465 n m to 595 nm when binding to protein occurs (141-142). Therefore, by 
measuring the absorbance at 595 nm, protein concentration in the sample can be 
estimated from a standard curve and a simple calculation. 
A series of protein concentration standards were prepared by serial dilution of 100 
|j.g/ml stock bovine serum albumin (fraction V, Rockland immunochemicals, inc., 
Gilbertsville, PA, USA). The concentrations were 0, 10, 20, 30, 40, 50 and 60 |ig/ml. 
Protein samples were assayed at three dilutions: 1:800, 1:1600 and 1:3200. Each 
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standard and sample was assayed in duplicate. For this assay, 40 |il of protein assay 
dye reagent concentrate was added to each well in a 96-well microtiter plate. Then 
160 |Lil standards or diluted samples were pipetted into appropriate labeled wells. The 
contents were mixed by placing the microtiter plate on a plate shaker and shaking for 
10 sec. The plate was incubated at room temperature for 5 min, and the absorbance at 
570 n m (OD570) was taken within 1 hr after mixing of reagent with standards or 
samples. The protein concentrations were determined from a standard curve. The 
concentrations of protein samples in the downstream reaction were adjusted to 1 |.ig. 
2.6.2 Real-time PGR reaction 
Real-time P G R was carried out in a 96-well P G R microplate (Axygen Scientific Inc, 
Union City, CA). To each well were added a master mix of reagents (includes TS 
telomerase substrate, Taq polymerase, reverse primer for TS telomerase product 
amplification, and dNTPs, under appropriate buffer condition) for the telomerase 
reaction, which comprised 12.5 2X Q T D premix and 11.5 |al P G R qualified water 
supplied in the kit. One microliter of tissue extract from spleens of 5 animals/group, 
either heat inactivated (85°C for 10 min) to destroy telomerase or non-heat inactivated 
was added to the appropriate wells in the P G R plate. Serially diluted standards 
labelled SI to S8, prepared from stock solution (0.5 amol) of TSR8 oligonucleotide 
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containing 8 telomeric repeats (supplied in the kit) were added to appropriate wells. 
The concentrations of TSR8 in standards SI to S8 were 0.5, 0.1, 0.02, 0.004，0.0008, 
0.00016, 0.000032 and 0.0000064 amol, respectively. Heat inactivated tissues, which 
had their telomerase destroyed, serve as negative controls for the reaction. The P G R 
plate was then sealed with self-adhesive (Bioplastics BV, Landgraaf, the Netherlands), 
and placed in a thermocycler with a real-time detection module (iCycleriQ Multicolor 
Realtime P G R detection system, Bio-Rad Laboratories, Inc., Hercules, CA, USA). 
The plate with its contents was incubated at 25。C for 20 min for telomerase to add 
six-base-repeats (GGTTAG) to TS. The temperature was then raised to 95®C for 10 
min, which caused the inactivation of telomerase and the activation of Taq D N A 
polymerase, which starts the PGR. The P G R cycle comprising of 30 sec at 95°C for 
denatiiration, 30 sec at 60°C for annealing and 30 sec at 72°C for extension, was 
performed for 40 cycles. The P G R product formation was detected directly by 
measuring the fluorescence resulting from binding of S Y B R green dye to 
double-stranded D N A during the annealing step. Any telomerase present in the 
reaction mixture would elongate the TS. Higher telomerase activity would lead to 
more and longer TS product (template for P G R reaction). The latter would lead to 
greater amount of double-stranded D N A at the annealing step of PGR, and hence 
stronger fluorescence signal. More templates present would lead to earlier appearance 
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of the fluorescence signal, and hence a smaller threshold cycle (CT). The smaller 
threshold cycle signifies higher tissue telomerase activity, leading to more TS 
elongation and hence more P G R template. 
2.6.3 Melt Curve 
After real-time P G R reaction, the P G R products were subjected to melt curve analyses. 
This involved the raising of temperature to 95°C and then lowering it to 45°C at a rate 
of per 10 sec with recording of the fluorescence. The initial elevation of 
temperature to 95°C causes denaturation of PGR products. With gradual lowering of 
the temperature, different P G R products will form a double-stranded structure with 
S Y B R green dye and give a fluorescence signal. The temperature at which this occurs 
corresponds to the melting point for that P G R product. The signal intensity is directly 
proportional to the amount of P G R product present in the sample and these increase 
sharply when the temperature reaches the melting temperature of one of the products. 
The plot of derivatives of fluorescence against the temperature gives a melt curve. A 
peak higher than the background noise in a melt curve signifies the presence of a P G R 
product derived from telomerase activity. If the peak is lower than the background 
noise, it signifies absence of telomerase activity. 
41 
2.7 Detection of mouse telomerase reverse transcriptase component 
(mTERT) mRNA expression by reverse transcriptase-
polymerase chain reaction (RT-PCR) 
2.7.1 Total RNA extraction 
Total R N A in spleen tissue was extracted using QIAgen RNeasy total R N A extraction 
kit (QIAGEN, Hilden, Germany). The tissue homogenization buffer (RLT buffer) was 
prepared by adding 10 pJ 2-mercaptoethanol per 1 ml RLT stock solution. Mouse 
spleen tissue weighing about 20 m g was sliced and homogenized in 600 i^l of RLT 
buffer (supplied in kit) by tissue homogenizer (Brinkmann Instruments, Westbiiry, NY, 
USA). The homogenate was transferred to QIAshredder spin column for further lysis. 
The column was spun at 8000 g in a benchtop centrifuge for 5 min. The supernatant 
was transferred to a new 2 ml microcentrifuge tube. Six hundred microliters 70% 
ethanol was added to the supernatant and mixed immediately by aspiration. Seven 
hundred microliters of siipernatant-ethanol mixture, including precipitate, was applied 
immediately to RNeasy mini-column supplied with the kit and fitted to a 2 ml 
collection tube. The column was centrifuged for 15 sec at 8000 g in a benchtop 
centrifuge. The filtrate was discarded. The remaining 500 |.il supernatant-ethanol 
mixture was applied to the same column, centrifuged, and the filtrate was again 
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discarded. Next, 700 pJ of R W l buffer supplied was added to the RNeasy column and 
centrifuged for 15 sec at 8000 g in a microcentrifuge to wash the column. The filtrate 
and the collection tube were discarded. The column was transferred to a new 2 ml 
collection tube. Five hundred microliters of RPE buffer was applied to the column and 
centrifuged in microcentrifuge for 15 sec at 8000 g. The filtrate was discarded. 
Another 500 RPE buffer was added to the column and centrifuged for 2 min at 
8000 g to dry the column. Finally, R N A was eluted in a 1.5 ml collection tube by 
adding 50 water to the column and centrifuged for 1 min at 13000 rpm. The 
absorbance at 260 nm was measured using a spectrophotometer (Nanodrop, 
Wilmington, USA) and the R N A concentrations were calculated using the following 
formula: 
RNA in fig/ml = (OD260^40) ^dilution factor 
The extracted R N A was kept in a -80°C freezer until further analysis. 
R N A integrity was confirmed by running 1 |ag R N A in a 2 % agarose gel (1 g agarose 
in 50 ml IX T A E buffer). 
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2.7.2 RT-PCR 
Reaction mixture for RT-PCR was prepared using reagents supplied in kit as follows: 
0.2 m M dNTP mix, 1 |.iM mTERT658F forward primer, 1 iiM mTERT950R reverse 
primer (or 1 \.lM L19F m R N A forward and 1 |.iM L19R m R N A reverse primers), 1 
m M MgS04, 0.1 ii/|.il of Avian Myeloblastosis Virus (AMV) reverse transcriptase, 0.1 
ii/|al Thermus flavus (Tfl) D N A polymerase, and 1X AMV/Tfl buffer. The mixture was 
pipetted into a thin-walled 0.2 ml P G R tube, followed by 0.1 |ig mouse spleen total 
R N A as template. The tubes were then placed in thermocycler (PTC-200, Peltier 
Thermal Cycler, M J Research, Inc, USA). A M V reverse transcriptase transcribed 
m T E R T m R N A at 48°C for 45min. The reaction mixture was then heated to 94°C for 
2 min to inactivate A M V reverse transcriptase and denature R N A , c D N A and primers. 
The P G R involved 30 sec at 94°C for denatiiration, 1 min at 56°C for annealing and 2 
min at 68。C for extension. The optimal number of cycles required was determined in 
a pilot run of P G R with 11 sets of the same reaction mixture. The P G R was started 
with all tubes placed in a thermocycler. After the start, one tube at a time was removed 
at cycles 20，22, 24, 26, 28, 30, 32, 34, 36, 38 and 40. The P G R products were 
analysed following agarose gel electrophoresis. From the 11 reactions with different 
cycle numbers, the band corresponding to 292 kbp, (RT-PCR product of mTERT) was 
visualized and measured deiisitometrically. The band density was plotted against cycle 
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number to find the log phase of P G R product generation. The log phase of P G R 
reaction occurred at cycle 25, which was thus chosen for the subsequent RT-PCR of 
m R N A for m T E R T in mouse spleen extracts. The same procedure was also repeated 
for L19 ribosomal m R N A primers, which also yield log phase production at cycle 25. 
After this pilot study, the extracts of total R N A from spleens were subjected to 25 
cycles of 30 sec at 94°C for denaturation, 1 min at 56°C for annealing and 2 min at 
68°C for extension for both m T E R T and LI9 ribosomal m R N A . 
2.7.3 Agarose gel electrophoresis of RT-PCR products 
Two percent agarose gel was set and electrophoresis was run for the visualization of 
RT-PCR product. The agarose gel was prepared by dissolving 1.4 g agarose in 70 ml 
IX T A E buffer. The mixture was heated in a microwave oven until completely 
dissolved. The mixture was allowed to cool to about 50°C, and 3.5 ethidiiim 
bromide (EtBr) added so that the RT-PCR product in the gel could be visualized under 
U V illumination. Five microliters RT-PCR product was mixed with 1 |li1 6X gel 
loading buffer, which comprised of 15% (v/v) glycerol, 0.25% (w/v) bromophenol 
blue, 240 m M Trizma base, 120 m M glacial acetic acid, and 6 m M EDTA. Three 
microliters 100 bp D N A marker was loaded and run along with the samples for 
product size estimation. Electrophoresis was carried out at 120 V for 35 min. The gel 
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was visualized and a gel image was taken in a U V illuminator (Syngene, Synoptics 
Ltd, Cambridge, UK). Band intensity was determined by Quantity One software 
(Bio-Rad Laboratories, Inc., Hercules, CA, USA). 
2.8 Detection of mouse TERT (mTERT) by Western blotting 
2.8.1 Nuclear protein extraction 
A piece of tissue slice weighing 30 m g was resuspended in 500 |il tissue lysis buffer, 
which comprised of 40 m M KCl, 10 m M HEPES pH 7.0, 3 m M MgCb, 5 % glycerol, 
0.2% Nonidet P-40, 2 |ig/ml leiipeptin, 8 |ag/ml aprotinin, 0.5 m M PMSF, and 1.0 m M 
D T T (143). The tissue was homogenized by tissue homogenizer (Brinkmann 
Instruments, Westbury, NY, USA). The disrupted cells in suspension were centrifuged 
for 20 min at 11000 x g. The supernatant was transferred to a fresh tube. This was the 
cytoplasmic fraction. One hundred and fifty microliters of nuclear buffer, 0.42 M KCl, 
20 m M HEPES pH 7.9, 1.5 m M MgCb, 0.2 m M EDTA, 25% glycerol, 2 |ig/ml 
leupeptin, 8 |ig/ml aprotinin, 0.5 m M PMSF, and 0.5 m M D T T was added to 
resuspend the crude nuclei pellet by retropipetting. The tube was shaken gently for 30 
min at 4°C, and centrifuged for 5 min at 20800 x g (144). The supernatant was 
transferred to a clean, chilled tube. The content was snap-frozen with liquid nitrogen 
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and stored at -70°C until analysis. 
2.8.2 Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) 
The gel was prepared as follows: 10% separating (10% acrylamide/bis-acrylamide, 
0.375 M Tris-HCl, pH 8.8’ 0.1% SDS, 0.1% APS and 0.04% N，N，N，N -Tetramethyl-
Ethylenediamine (TEMED)) and 4 % stacking (4% acrylamide/ bis- acrylamide, 0.125 
M Tris-HCl, pH 6.8, 0.1% SDS, 0.1% APS and 0.04% TEMED). The gel was allowed 
to set, followed by the loading of 20 jil spleen protein extract. The gel was run at 100 
V for 3 hrs in IX electrophoresis buffer (25 m M Trizma base, 0.192 M glycine, 0.1% 
(v/v) SDS). The proteins were then transferred to polyvinylidene fluoride (PVDF) 
membrane (Bio-Rad Laboratories, Inc., Hercules, CA, USA). The P V D F membrane 
was treated with methanol (Beijing Chemical Works, Beijing, China) for 5 min and 
washed with autoclaved Milli-Q water for 5 min. The wash procedure was repeated 3 
times before blotting. The blotting cassette consisted from anode to cathode of the 
following: sponge, Whatman 3 M M paper, SDS-PAGE gel, P V D F membrane, 
Whatman 3 M M paper and sponge. The cassette was connected to a 100 V power 
supply, and electroblotting performed for 1 hr in IX transfer buffer, with an ice 
chamber to avoid overheating. While the transfer was in progress, a blocking buffer 
comprising of 2 % (w/v) non-fat dry milk powder (Nestle, Vevey, Switzerland) in 
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wash buffer (0.04 M Trizma base, 1 M Sodium Chloride, 0.1% (v/v) Tween-20, pH 
7.5) was prepared. After the transfer, the membrane was soaked in the blocking buffer 
overnight at 4°C. Initially, the membrane was incubated with an in-house primary 
antibody specific to mouse telomerase-reverse-transcriptase (mTERT) namely m476 
(145) at 1:1000 dilution. After 2 hrs incubation, the membrane was washed several 
times with wash buffer. The washed membrane was incubated for 30 min in 
biotinylated link reagent (DakoCytomation, Inc, Carpinteria, CA, USA) diluted 1:50, 
followed by 30 min incubation in streptavidiii horseradish peroxidase 
(DakoCytomation, Inc, Carpinteria, CA, USA) diluted 1:50. The membrane was 
washed several times and 100 of Lumigen TMA-6 (Amersham Biosciences 
Piscataway, NJ, USA), a proprietary substrate for horseradish peroxidase dissolved in 
tris buffer and 3.2% (v/v) ethanol, was added to the membrane. The chemiluminescent 
reaction for m T E R T protein was detected by exposing X-ray film to the membrane for 
10 sec. However, only an 85 kDa protein was detected, which was not consistent with 
the size of m T E R T protein, i.e., 125 kDa. Therefore, the subsequent Western Blotting 
were performed with a commercial (Santa Cruz Biotechnology, Inc., CA, USA) 
m T E R T antibody, which reacts with a 125 kDa protein. The membrane with 
PAGE-resolved proteins were blotted and then incubated with the commercial 
primary antibody at 1:500 dilution. After 2 hrs incubation, the membrane was washed 
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several times with the wash buffer. Anti-rabbit secondary antibody conjugated with 
horseradish-peroxidase (Amersham Biosciences Piscataway, NJ, USA) diluted 1:5000 
was added and incubated for 2 hrs. The membrane was washed with wash biiffer 
several times. One hundred microliters containing a proprietary substrate for 
horseradish peroxidase, Lumigen TMA-6 (Amersham Biosciences Piscataway, NJ, 
USA), dissolved in tris buffer and 3.2% (v/v) ethanol, was added to the membrane. 
The chemiluminescent reaction for m T E R T protein was detected by exposing X-ray 
film to the membrane for 10 sec. The Western blotting procedure was repeated with 
primary antibody specific to histone protein instead of antibody specific to m T E R T 
protein as an internal control of amount of nuclear protein expression. The exposed 
X-ray film was scanned with densitometer (Bio-Rad Laboratories, Inc., Hercules, CA, 
USA) and the band intensity of m T E R T and histone were analysed using Quantity 
One software (Bio-Rad Laboratories, Inc., Hercules, CA, USA). 
2.9 Statistics 
All data are expressed as means 士 1 SD. For comparisons between two paired 
variables, Wilcoxon signed rank test was used. For multiple comparisons between the 
five treatment groups, one-way analysis of variance (ANOVA) was used followed by 
Tukey's H S D test. For the measurement of linear correlation between two variables, 
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the Pearson correlation coefficient was used with two-tailed test of significance. Level 
of significance was set at p < 0.05. All statistics were calculated using SPSS for 
Windows, Version 11.0 (SPSS, Chicago, IL). 
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3. Results 
3.1 Body and spleen weights of study animals 
Figure 3.1 summarizes the body weight of mice in different groups of animals before 
and after the treatment period. There was no significant difference in body weight 
among the five groups before the start of the treatment. After 21 days of treatment, the 
mean body weight of the stressed mice (25.91 士 1.54 g) and dexamethasone treated 
mice (23.95 士 0.96 g) were lower than control mice (27.15 士 1.08 g). The difference 
in body weight between dexamethasone treated and control mice was statistically 
significant (p < 0.001，analysis of variance (ANOVA), Tukey's H S D test), while 
vehicle injected (27.25 士 1.18 g) and adrenalectomized mice (26.82 士 0.85 g) had 
body weights similar to control mice. 
After 18 days of treatment, there were significant (Wilcoxon signed ranks test, 2 tails) 
increase in body weights of aclienalectomized (p = 0.005), vehicle treated (p = 0.005) 
and control (p = 0.028) animals. Body weight of dexamethasone treated mice showed 
a significanl decrease after the treatment period (p = 0.005, Wilcoxon signed ranks 
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Figure 3.1. Box plot of body weight (in gram) among different treatment groups of 
mice before and after treatment, n = 10. The box plot represents, the median (heavy 
black), the box (25 to 75 percentile limits) and whiskers (the spread of largest and 
smallest observed values that are not statistical outliers) (the same applies to all 
subsequent box plot diagrams). The differences between different groups are indicated 
by asterisks. * p = 0.004，** p < 0.001 analysis of variance (ANOVA)，Tukey's H S D 
test, *** p = 0.005 compare with their respective body weight before treatment 
(Wilcoxon signed rank test, 2 tails), **** p = 0.028 compare with body weight of 
adrenalectomized mice before treatment (Wilcoxon signed rank test, 2 tails). 
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Figure 3.2 shows the weights of spleen collected from mice in different treatment 
groups. Dexamethasone treated mice had significantly lower spleen weights (53.6 士 
17.7 mg) compared with control mice (95.8 土 7.9 mg，p < 0.005, A N O V A , Tukey's 
H S D test). Stressed mice also had lower spleen weights (83.3 士 13.8 mg) compared 
with control group, but the difference was not statistically significant. 
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Figure 3.2 Box plot of mouse spleen weight among different treatment groups (. n = 
10). The significant (ANOVA, Tukey's H S D test) differences are represented by 
asterisks, * p = 0.002, * * p < 0.001. 
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3.2 Serum corticosterone level 
Figure 3.3 shows the corticosterone concentration in sera of animals after 18 days of 
various treatments. Mice given dexamethasone treatment had lower serum 
corticosterone levels (6.618 土 5.864 ng/ml) compared with control (102.049 士 74.594 
ng/ml) and vehicle treated mice (124.494 土 101.592 ng/ml). The stressed mice had the 
highest serum corticosterone levels (179.676 士 69.462 ng/ml) among the five groups 
of mice, but only the dexamethasone treated animals' corticosterone was statistically 
significantly lower than the rest of the animals. Surprisingly the adrenalectomized 
animals had corticosterone (116.268 士 78.000 ng/ml) in the range comparable to 
control, vehicle treated and stressed animals. 
3.3 Telomere lengths of spleen 
Figure 3.4 shows the images of Southern blotting for splenic telomere lengths for 
individual animals in the five study groups. The mean 士 1 SD of telomere lengths 
(expressed as kbp) for spleen tissues are shown in figure 3.5. There was no significant 
difference in the telomere lengths in any of the groups 
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Figure 3.3 Box plot of mouse serum corticosterone levels among different treatment 
groups, (n 二 10 except vehicle injected where n = 9). The significant (ANOVA, 
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Figure 3.4 Southern Blotting for telomeric repeats of genomic D N A extracted from 
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Figure 3.5 Box plot of mice telomere length (in kbp) of spleen genomic D N A in the 
five study groups. 
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3.4 Telomerase activity of spleen tissue 
Figure 3.6a shows the CT cycle numbers for various concentrations of TSR8 standards. 
There was an inverse relation between the concentration of TSR8 standards and the 
CT cycle number. These increased by a factor of two for every five fold decrease in 
TSR8 concentration. The concentrations of TSR8 standards used are summarized in 
table 3.1, and figure 3.7 shows a standard curve of CT cycle against Logio (TSR8 
concentration), which yielded an equation: y = -3.219x + 19.106 (R^ = 0.9762). This 
equation was used for calculating the product yield in the PGR reaction of spleen 
tissue extracts. The melt curves (figure 3.6b) show the derivatives of fluorescence 
signal for each of the standard subjected to steady decrease in temperature from 95°C 
to 45"C. The peak hybridization occurred at a temperature of 80°C and 81。C Whilst 
CT cycle number was inversely related to the concentration of the TSR8, the same was 
not the case with derivative of fluorescence. Generally standards with more TSR8 
produced more fluorescence, but standards S7 and S8 produced fluorescence which 
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Figure 3.6 (a) Real-time PCR fluorescence profile of different concentrations of TSR8 
positive control. TSR8 standards labeled SI to S8 (from highest to lowest 
concentration) had 0.5, 0.1, 0.02’ 0.004，0.0008, 0.00016, 0.000032 and 0.0000064 
amol respectively, (b) Melt curves of real-time PCR products obtained with various 
concentrations of TSR8 standards as template. Same colours are used for each 
standard in figures a and b. Traces in figure 3.6b below 72°C are indicative of 
background noise with little telomerase activity. 
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Identifier Cone ( a m o l ) Ct Log conc 
5 1 0 . 5 1 9 . 7 - 0 . 3 0 1 0 3 
5 2 0 . 1 2 1 . 9 - 1 
5 3 0 . 0 2 2 4 . 4 - 1 . 6 9 8 9 7 
5 4 0 . 0 0 4 2 7 . 9 - 2 . 3 9 7 9 4 
5 5 0 . 0 0 0 8 2 9 . 1 - 3 . 0 9 6 9 1 
5 6 0 . 0 0 0 1 6 3 1 . 6 - 3 . 7 9 5 8 8 
5 7 0 . 0 0 0 0 3 2 3 4 . 7 - 4 . 4 9 4 8 5 
5 8 0 . 0 0 0 0 0 6 4 3 4 . 3 - 5 . 1 9 3 8 2 
B l a n k 0 3 5 . 2 
Table 3.1. Concentrations of TSR8 oligonucleotides in reaction mixture and their 
corresponding CT cycle, along with Logio concentrations. 
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Figure 3.7. Standard curve of Cj cycle vs. LogioTSRS concentration. The inset shows 
the equation for the relationship. 
60 
In the non-heat inactivated tissue samples, the mean 士 1 SD CT cycle numbers for 
telomerase activity derived from fluorescence profiles were: 30.300 士 2.072 (n = 5) 
for control group; 28.640 士 2.350 (n = 5) for stressed group; 29.700 士 1.311 (n = 3) 
for vehicle treated group; 30.9400 土 1.936 (n = 5) for dexamethasone treated group; 
and 31.75 ± 1.987 (n = 4) for adrenalectomized group. Fluorescence profiles and melt 
curves for each study group are shown in appendix 1. However, there was one sample 
in the vehicle treated group, where CT cycle number could not be obtained, hence no 
telomerase activity. 
Heat-inactivated negative control tissues, should theoretically not yield CT cycle 
numbers. However, out of 25 samples subjected to heat inactivation, 21 yielded a CT 
cycle number. But even the blank control without any telomerase or TSR8 added, 
yielded a Cj cycle number of 35.2. With this as a cut-off number, 13 (62%) out of 
the 21 heat inactivated samples had a larger CT cycle number. The remaining eight 
heat-inactivated samples had Cj cycle number smaller than 35.2. However, none of 
these displayed hybridization fluorescence in the melt curve higher than background 
noise. 
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Figure 3.8 shows the box plot of telomerase activity expressed as CT cycle numbers, 
where smaller numbers represent higher telomerase activity. Based on the CT cycle 
number, the stressed animals had the highest and the adrenalectomized the lowest 
telomerase activity. The control, dexamethasone treated and vehicle injected mice had 
similar level of telomerase activity, but there were no statistically significant 
differences in telomerase activity in spleens between any of groups. 
Based on the formula y = -3.219x + 19.106 where y is Cj cycle number of spleen 
protein sample and x is concentration of product, the amounts of telomerase product 
calculated are shown in figure 3.9. Amounts of PGR product present among different 
groups were not statistically significant. The amounts of PGR product in heat-
inactivated samples were negligible. 
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Figure 3.8 Box plot of telomerase activity (in Cj cycle) in non-heat inactivated and 
heat inactivated spleen extracts of five animals from each group. Four heat-inactivated 
samples had no C丁 cycle number, hence no telomerase activity. In the other 21 
heat-inactivated samples with a Cj cycle number, 13 had value greater than 35.2 
obtained for water blank without any telomerase activity or TSR8 standards. There 
were no significant differences in telomerase activity for non-heat spleen tissues from 
different groups of animals. 
63 
. 0 0 4 1 
. 0 0 3 • 
二 .002 • 
"o 丁 
E 
^ .001 • 工 T 
o 一 r n 
o 
一 J J 一 一 Heat inactivated 
•§ 0 . 0 0 0 . ~ ~ _ y ~ ~ ~ ^ ~ 
^ [ZZ -
a: 
o r r - i 
a . - 0 0 1 ——. . . . . — — I 1 1 3 + 
N = 5 4 5 4 4 3 5 5 5 5 
Con t ro l V e h i c l e i n j ec ted A d r e n a l e c t o m i z e d 
S t r e s s e d D e x a m e t h a s o n e in ject 
Treatment 
Figure 3.9. Box plot of concentrations of real-time PCR product after telomerase 
activity assay of spleen tissue protein extract among treatment groups. Heat-
inactivated samples were regarded as having no telomerase activity. Only a few of the 
heat-inactivated samples have real-time PCR products, and the concentrations of them 
are closed to zero. 
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3.5 Correlation between serum corticosterone level and telomere 
length 
Figure 3.10 shows the scatter plot of spleen genomic D N A telomere length against 
serum corticosterone level in animals. The data from dexamethasone treated animals 
was excluded as their serum corticosterone level was suppressed by the potent effect 
of dexamethasone, although the synthetic glucocorticoid would still be expected to 
exert its effect, in any, on the telomere length regulation. However, there was no 
correlation between serum corticosterone and spleen genomic D N A telomere length (r 
=0.07, p = 0.672). 
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Figure 3.10. The relationship between telomere length of spleen genomic D N A and 
corticosterone level in control, adrenalectomised, vehicle and stressed mice. 
Dexamethasone treated animals excluded from the analysis. 
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3.6 Correlation between serum corticosterone level and telomerase 
activity 
Figure 3.11 shows the scatter plot of splenic telomerase activity versus the serum 
corticosterone concentration in four groups of animals. As with the previous 
correlation, data obtained from mice treated with dexamethasone were excluded, but 
again the synthetic glucocorticoid may have influenced telomerase activity. There was 
a negative correlation between serum corticosterone and telomerase activity, but it 
was not statistically significant (r = -0.412, p = 0.080). 
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Figure 3.11. The relationship between telomerase activity of mice spleen genomic 
D N A and corticosterone level in control, adrenalectomised, vehicle and stressed mice. 
Dexamethasone treated animals excluded from the analysis. 
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3.7 Correlation between telomere length and telomerase activity 
Figure 3.12 shows the scatter plot of telomere lengths of splenic genomic D N A and 
telomerase activity in the tissue extract. Data obtained from mice treated with 
dexamethasone were excluded as mentioned previously in section 3.5. It may interfere 
with the result of telomere length to telomerase activity. There was a negative 
correlation between splenic genomic D N A telomere length and telomerase activity, 
but this was not statistically significant (r = -0.116, p = 0.637). On the other hand, 
since dexamethasone is a very potent synthetic glucocorticoid, it may have had an 
impact on telomere lengths and telomerase activity. Therefore, including the data for 
the two parameters under investigation for dexamethasone treated group altered the 







2.5 • • 
• 
Q： ^ ^ ^ ^ ^ ° 
c 1 5 • • 口 
OJ 丨.° • 
0) 
I ° ° 
H 1 0 • 思 ^ ^ Rsq = 0.0134 
24 26 28 30 32 34 36 
T e l o m e r a s e A c t i v i t y ( C t ) 
b 3.0 1 
• 
• 
2 5 ' o 
• 
2 . 0 _ 口 
D — • 
CL _ _ _ _ 
- Q • • 
乞 • — 
g 1 5 , ° ° 
Ctl � O 
I— • • � 
I ° ° 
^ 1.0 , ^ ^ ^ ^ Rsq = 0.0062 
24 26 28 30 32 34 36 
T e l o m e r a s e A c t i v i t y ( C t ) 
Figure 3.12. The relationship between telomere length of splenic genomic D N A and 
telomerase activity in mice splenic tissue, (a) Data from dexamethasone treated mice 
excluded, and (b) data from dexamethasone treated mice included 
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3.8 Detection of telomerase reverse transcriptase component 
(mTERT) mRNA expression by RT-PCR 
Figure 3.13 shows the fluorescent images of the RT-PCR products of m T E R T m R N A , 
along with the LI9 m R N A in the spleen tissues in all animals in the study. The 
amount of RT-PCR product was directly proportional to the amount of m T E R T 
m R N A present in spleen tissue extract. The m T E R T m R N A expressions were 
normalized by dividing their band densities with the corresponding LI9 ribosomal 
m R N A density value. The relative expression of m T E R T to LI9 (mean 士 1 SD) 
were: 0.498 士 0.157 for control mice, 0.522 士 0.211 for stressed mice, 0.430 士 0.199 
for vehicle treated mice, 0.532 士 0.138 for dexamethasone treated mice and 0.511 士 
0.184 for adrenalectomized mice (figure 3.14). 
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Control mice 
Mouse 1 2 3 4 5 6 7 8 9 10 
m T E R T r a ra • • m ra a _ • _ Me謝atio 
0.682 0.778 0.307 0.460 0.410 0.645 0.482 0.448 0.469 0.302 
= 0.498±0.157 
L19 c r i n a r a a Q a c i ] 【 ： . ] [ : ] 
Stressed mice 
Mouse 1 2 3 4 5 6 7 8 9 10 
m T E R T — • • • — • • • • m m r a a Mean ratio 
0.435 0.932 0.372 0.338 0.318 0.436 0.817 0.508 0 404 0.663 
= 0.522±0.211 
L19 D • w m D 國 ra • 口 
Vehicle injected mice 丨：: 
Mouse 1 3 4 5 6 7 8 9 10 
丨I 
mTERT i r a • • • • • m H i Q Mea. ratio 1 
0.766 0.172 0.377 0.322 0.432 0.599 0.428 0.176 0.601 
^ ^ ^ ^ ^ ^ •••••• _ _ — , „ = 0.430±0.199 I 
L19 【::；:J i ^ H E 3 E a ^ C Z U m � : � 
Dexamethasone injected mice 
Mouse 1 2 3 4 5 6 7 8 9 10 
m T E R T ^ a B B • • n Q • • • Mean ratio 
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mTERrBBI E 3 HH • • m E J I Z l I M 1^9 Mean ratio 
0.575 0.865 0.332 0.443 0.411 0.563 0.359 0.629 0.263 0.673 
=0.511±0.184 
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Figure 3.13. Fluorescent images of RT-PCR products of m T E R T and LI9 ribosomal 
m R N A from spleens of each animal in the five treatment groups. RT-PCR product 
using m R N A templates of the same mice were run in the same gel so that their band 
density will not be affected by variations between each experimental run. The values 
between m T E R T and LI9 ribosomal m R N A fluorescent bands are the densitometric 
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Figure 3.14 Box plot of m T E R T m R N A expression relative to LI9 m R N A in spleen 
tissue among different treatment groups. There are no statistically significant 
differences among treatment groups. 
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3.9 Detection of mTERT by Western blotting 
Figure 3.15 shows the Western Blot results of m T E R T protein extracted from spleens 
of all animals in the study. The dexamethasone treated mice had lighter bands for both 
histone and m T E R T protein. The expression of m T E R T protein relative to the 
corresponding histone protein is shown in the figure 3.16. The m T E R T protein 
expressions (mean 土 1 SD) were: 1.891 士 0.753 for control mice; 2.427 士 0.888 for 
stressed mice; 1.900 土 0.406 for vehicle treated mice; 2.359 士 0.806 for 
dexamethasone treated mice and 2.266 士 0.750 for adrenalectomized mice. The 
m T E R T expression did not show any significant difference among five groups of 
mice. 
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Figure 3.15. Western blotting of m T E R T and histone protein of spleen tissue nuclear 
extracts of mice 3-9 in the five study groups. The molecular weights of m T E R T and 
histone protein are 120 and 15 kDa. The groups are abbreviated as S: stressed, O: 
vehicle treated, D: dexamethasone treated, C: control and A: adrenalectomized 
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Figure 3.16. Relative expression of m T E R T protein to histone protein in spleen tissue 
nuclear extract. None of the m T E R T expressions were statistically different in the five 
groups of animals. 
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3.10 Correlation between serum corticosterone level and mTERT 
mRNA /protein expression 
Figure 3.17 shows the scatter plot of mice m T E R T m R N A expression against serum 
corticosterone level. Data obtained from mice treated with dexamethasone was 
excluded as mentioned previously in section 3.5. However, there was no statistically 
significant correlation between the serum corticosterone concentration and m T E R T 
m R N A expression (r = 0.239, p = 0.144). m T E R T protein expression also had no 
statistically significant correlation with serum corticosterone concentration (r = -0.182, 
p = 0.354, figure 3.18) 
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Figure 3.17. The relationship between m T E R T m R N A expression and corticosterone 
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Figure 3.18. The relationship between m T E R T protein expression and corticosterone 
level in mice serum. 
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4. Discussion 
W o m e n caring for sick children had shorter telomeres in their peripheral blood 
lymphocytes compared to women who did not have to look after sick children (90). 
The former women were perceived to be under a lot of stress because of their 
children's sickness. Stress stimulates the stress centres in central nervous system 
(CNS) including the parvocellular neurons of CRH, the parventricular nuclei (PVN) 
of the hypothalamus, the locus ceruleus (LC) which secret C R H and noradrenergic 
cells in medulla and pons (LC/NE system) (100-101). H P A axis is triggered, and 
finally the adrenal glands start to secrete excessive amounts glucocorticoids. The 
function of the glucocorticoids is to lessen the strain of stress. Therefore it is quite 
possible that women under stress, may have had shorter telomeres, because of the 
activated H P A axis and the resultant excessive secretion of Cortisol. Cortisol is the 
main glucocorticoids secreted by the human adrenal gland. However, the levels of 
glucortiocoids in the stressed and the control women were not reported in the above 
study (90). Glucocorticoids have profound negative effects on the white blood 
corpuscles, including causing their destruction (102，146)，hence their use in the 
treatment of leukemia and other states involving the over activation of the immune 
system. 
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The primary aim of this project was to examine the role of glucocorticoids on 
telomere length using a mouse as a model, with spleen being chosen as the source of 
lymphocytes. 
In the present study 50 Balb/c mice, aged 6-8 weeks were divided into 5 groups of 10 
animals. The groups comprised of control animals, stressed animals which were 
subjected to stress in the form of orbital shaking for 8 hours per day for three weeks, 
dexamethasone treated animals given 1 |ig of the steroid in peanut oil (vehicle) every 4 
days, vehicle treated animals and an adrenalectomised group. 
4.1 Serum corticosterone level in mice 
As expected the stressed mice had higher corticosterone level compared with control 
mice, which was within the limits for circulating levels of the steroid in normal mice 
(147). The corticosterone rise in the stressed animals is consistent with previous 
findings (102, 147). Orbital shaking thus exerted stress in the animals, triggering the 
activation of the HPA and elevation in the serum corticosterone. Dexamethasone 
treated mice had the lowest serum corticosterone concentration among the five 
treatment groups. Dexamethasone is a potent glucocorticoid which suppresses the 
secretion of corticosterone in mice by negative feedback mechanism on the HPA (148， 
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149). While the synthetic glucocorticoids may have lowered the serum corticosterone 
in the treated animals, it may still have exerted a glucocorticoid action in the treated 
animals. The animals treated with the vehicle alone had serum concentration in the 
same range as control mice, which means the injection action and peanut oil used did 
not exert stress or glucocorticoid activity in these animals. The dosage of 
dexamethasone can effectively suppress physiological glucocorticoid secretion, but 
because of it potent glucocorticoid activity, it serves as a positive control. 
Adrenalectomized mice, theoretically, should have had no serum corticosterone. 
However, the results showed that adrenalectomized mice had a mean serum 
corticosterone concentration of 116.268 士 78.000 ng/ml, similar to control mice 
(102.049 士 74.594 ng/ml). This was most likely due to incomplete removal of adrenal 
glands, as the remains of adrenal glands could be found during the dissection of 
adrenalectomized mice. Since the adrenal glands in rodents are very small weighing 
about 4 m g (150), and are embedded in fatty tissue, it is possible that the person 
performing the adrenalectomy, removed fatty tissue instead of the adrenal glands. 
Therefore, the data obtained from this group cannot serve as a negative control for 
animals without corticosterone. 
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4.2 Mice body weight and spleen weight 
Glucocorticoids in general are catabolic agents that cause muscle and protein wasting. 
Prolonged elevation in serum glucocorticoids level decreases body mass (120). After 
three weeks of treatment, control mice had significant increase in body mass, but not 
the stressed mice, where the body weight remained essentially unchanged. One of the 
reasons for the latter observation might have been disorientation caused by orbital 
shaking. This may have prevented the animals from consuming food. However, it was 
observed that animals moved freely inside the cage, and moreover the stressed 
group's replenishments for food and water were the same as those for animals in the 
other 4 groups. Therefore the decrease in body weight is most likely due to the stress 
related catabolic activities in mice rather than dietary restriction from the 
experimental procedure. 
As with stressed animals, dexamethasone treated mice had a significant decrease in 
body weight, which again supports the role of the steroid as a potent catabolic agent. 
As expected the vehicle treated mice had a significant increase in body weight after 
treatment period. For rodents with adrenal glands removed, there is usually body 
weight gain when animals are provided with normal diet, but the increase is less than 
control animals (151-153). The "sham" adrenalectomized mice had increase in body 
80 
weight, which is not surprising since they were identical to control and vehicle treated 
animals, which displayed an increase in body weight. 
Comparing the body weights before and after a 3-week treatment with-in a treatment 
group perhaps answers the question as to the exact effect of the treatment on body 
weight. Only the dexamethasone treated animals lost weight by about 2 grams during 
this period, whereas the weights of animals in the other four groups remained 
unchanged or increased insignificantly. Since dexamethasone is 25 fold more potent 
than naturally produced glucocorticoids, the dose administered to the mice may have 
supraphysiological. 
Body weight in the control mice also had a slight increase. Animals gain weight 
naturally as they grow older. Looking at the body weight data among groups 
transversely, we can compare effect of each treatment while eliminating the factor of 
natural growth. The body weight of stressed mice was smaller than control mice, and 
vehicle treated and adrenalectomized mice were slightly heavier than control, but the 
differences were not statistically significant. With higher levels of serum 
corticosterone, a body weight decrease was noticed. 
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If stress is present chronically, then the raised levels of corticosteroids may cause 
chronic damage to tissues or organs (110). Three weeks of stress slightly reduced the 
weights of spleen, without statistical significance, in animals exposed to eight hours 
of orbital shaking. While the spleen weights in the other three groups of animals were 
similar, the dexamethasone treated animals had the greatest reduction. With three 
weeks of treatment, spleen had decreased significantly in weight and appeared 
atrophied. The decrease in spleen weight reflects the immunosuppressive effect of 
glucocorticoid. The decrease in the spleen weights in the stressed animals was lower 
compared to controls, which correlates with the raised levels of corticosterone. The 
corticosterone concentration in a mouse varies from 20-200 ng/ml throughout a day, 
while a mouse under prolonged stress can have serum corticosterone concentration 
ranging from 150-500 ng/ml (147). The stressed mice had the highest serum 
corticosterone concentration among the five groups with mean 士 1 SD levels of 
179.676 土 69.462 ng/ml only. Therefore it can be assumed that the spleen weights in 
the four groups of animals other than dexamethasone treated animals, reflect the effect 
of circulating corticosterone at tissue level, including the white blood corpuscles. 
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4.3 Telomere lengths in the spleen tissue 
The big assumption made in the present study is that the decrease in telomere lengths 
in the lymphocytes of women caring for sick children was perhaps manifested by 
increased Cortisol levels. Unfortunately Cortisol levels were not measured in the 
aforementioned study, but were implicated as one of the mechanisms for shortening of 
telomere lengths in an editorial accompanying the publication (154). Significant 
differences in telomere lengths in the spleens of animals could not be demonstrated in 
the present study. While in Epel's study (90), women with longer period of caring had 
shorter telomere length. Duration might have a stronger association with telomere 
lengths than simply caregiver versus control status. Telomere lengths were related to 
the amount of perceived stress in both caregivers and controls. Also, perceived stress 
level in an experimental subject was correlated with her telomere length (90). 
The telomere lengths obtained in this project were not consistent with the other 
findings. Other studies have reported that mouse telomere lengths should be 20-60 
kbp long in mouse strains TgN(Hbb-bl)83Clo, W / W and Balb/c (66,155), while about 
2 kbp were obtained in the present study. There are several possibilities for the 
differences, namely (i) the mice in this study may have abnormally short telomere 
length; and (ii) shearing of the telomeric D N A may occur in pipetting or mixing 
83 
during extraction or handling process. Fragmentation of telomeric repeats is unlikely, 
as some precautions were taken during genomic D N A extraction process. For example, 
small pore size pipette tips were avoided and mixing was done gently in order to 
avoid shearing of genomic DNA. 
The correlation of corticosterone from all groups except for dexamethasone with 
telomere lengths produced no significant results. Thus it seems telomere lengths are 
not related to circulating corticosterone levels in mice. 
4.4 Telomerase activity in spleens 
T R A P assay for telomerase activity employs a synthetic oligonucleotide substrate 
which is lengthened by the telomerase, and the signal is amplified in a subsequent 
PGR. Higher telomerase activity in a mouse spleen extract signifies longer P G R 
product. Therefore, the fluorescence signal from a PGR product appears earlier, hence 
yielding a smaller CT cycle number. Larger CT cycle number represents weaker 
telomerase activity. Theoretically, if no telomerase activity was present in a sample as 
would be the case for heat inactivated tissues, since heat destroys telomerase, there 
should be no P G R product formed, and no increase in fluorescence signal from 
baseline and no Cj cycle number. However, some of heat-inactivated samples gave Cj 
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cycle close to 35, which was the number obtained for T R A P assay performed with 
water blank without telomerase. This may have been due to a non-specific reaction. 
This in P G R normally implies contamination, but all precautions were taken to avoid 
this. Assuming that CT cycle number of 35.2 truly represents a non-specific reaction, 
melt curve analysis of P G R products perhaps provides further evidence as to whether 
reactions resulted in P G R products due to telomerase activity. Products of telomerase 
reactions differ from each other by six-basepair increments, which have melting point 
characteristics close to each other. For positive telomerase reaction results, a broad 
peak started at 74°C and ended at 84°C with peaks between 80°C to 81°C in melt 
curves. For the heat inactivated tissue samples, there were no peaks at the stated 
temperatures, whereas for non-heat inactivated tissues peaks occurred, hence 
indicative of telomerase activity. 
As with telomere lengths, there was no significant trend in telomerase activity of mice 
in different treatment groups. Dexamethasone was shown to reduce telomerase 
activity in human multiple myeloma cells through the inhibition ofhTERT expression 
before the induction of apoptosis in vitro after one hour treatment period (155). An \n 
vivo study showed that apoptosis in Balb/c mice thymocyte occurred after three hours 
of intravenous injection of dexamethasone (lOOmg/lOg body weight), however, dose 
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of dexamethasone given to the animals seems to be very high (146). There was also a 
decrease in telomerase activity and telomere lengths due to morphological changes in 
nonviable cells undergoing apoptosis (146). In both studies, apoptosis was the final 
result following the reductions in telomerase activity and telomere lengths. However, 
the later study stated that the reductions in telomerase activity and telomere length 
were due to apoptosis of immature thymocytes. In the present study, dexamethasone 
treatment period was longer than the above two, therefore apoptosis was predicted. 
After clearance of apoptotic cells, the overall telomerase activity and telomere length 
in spleen cells would be the same as control mice. When looking at the effect of stress 
to telomerase activity in human, the chronically stressed human subjects, who might 
be expected to have higher serum Cortisol level, had similar telomerase activity to 
control subjects (90). But the telomerase activity was found to have correlation with 
self-percieved stress (90). 
Perceived stress in mice cannot be assessed. W e can only adjust the level of stress 
inflicted on the mice, e.g., speed of orbital shaking and its duration, which is difficult 
to quantify and compare. Moreover each mouse has different level of response to the 
same stressor. Serum corticosterone perhaps reflects the level of stress an animal has 
endured, and is more objective and easier to compare. While there appeared to be 
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negative correlation between serum corticosterone concentration and telomerase 
activity, this was statistically insignificant. In general it seems that serum 
corticosterone level is not the determining factor in telomerase activity regulation. 
If the primary function of telomerase is to extend the telomeres, then there should be 
some relationship between the telomerase activity and telomere lengths. However, 
when the data for all animals, irrespective of treatment were analyzed, there was no 
significant relationship between the two parameters. In somatic cells in humans, 
telomerase activity was not detected (70). However, transformed cell lines have 
telomerase activity, but their telomere lengths are minimal (70). Also, immortalized 
cells do not show telomerase up-regulation that maintains telomere lengths through 
alternative lengthening of telomeres (ALT), which is independent of telomerase 
activity (89). 
4.5 Correlation between serum corticosterone level and telomere 
length 
There was no correlation between serum corticosterone concentration and spleen 
genomic D N A telomere lengths (r 二 0.07, p = 0.672). Corticosterone secretion in 
dexamethasone treated mice were suppressed by the negative feedback mechanism 
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triggered by dexamethasone, therefore the serum corticosterone concentration was 
lower than physiological level. The telomere length measured from this group of mice 
would not only have been affected by serum corticosterone, but also dexamethasone. 
Therefore they were excluded in analysis. Although the adrenalectomized mice did 
not have their adrenal gland completely removed, they still had endogenous 
corticosterone secretion. The effect of endogenous glucocorticoid to their telomere 
length was thus valid for analysis. 
In Epel's study, the longer the care-giving period, the shorter the telomere length (90). 
It would seem that time is the critical factor for the shortening of telomere. Some 
caregivers had been looking after their ill children for 12 years, which was 
approximately 20% of lifespan for a person who might live to 70 years of age (156). 
In this study, the stress period for animals was three weeks, which is equivalent to 
about 3 % of lifespan of mice that normally live for about 78 weeks (1.5 years) 
(157-158). Therefore the administration of stress for three weeks perhaps was not 
long enough to mimic the perceived stress experienced by women looking after sick 
children. Extending the stress treatment period to 16 weeks (4 months) perhaps may 
have yielded a better correlation between corticosterone and telomere lengths. 
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4.6 Correlation between serum corticosterone level and telomerase 
activity 
While the mice with higher serum corticosterone concentration tended to have higher 
telomerase activity, the data did not result in statistically significant linear correlation 
between serum corticosterone in the four groups, excluding dexamethasone treated 
group, and Cj cycle number (r = -0.412, p = 0.080). Again assuming that women 
caring for sick children had higher Cortisol levels, then the decreased telomerase 
activity in their lymphocyte perhaps may be related to telomerase suppression because 
of elevated Cortisol level (90，146,155). 
4.7 Mouse telomerase reverse transcriptase component (mTERT) 
mRNA expression 
Proteins such as telomerase are normally translated from messenger RNAs, which are 
transcribed from the genomic D N A . The gene for mouse telomerase is located on 
chromosome 5 (71). Telomerase has several components, one of which is a reverse 
transcriptase component (mTERT) which is the functional part that extends the 
telomere using its R N A component coding the complementary sequence of telomere 
as a template. Therefore, measuring the amount of m R N A coding for the m T E R T 
protein gives supporting evidence in m T E R T protein expression and hence telomerase 
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activity found in samples. 
The RT-PCR of m T E R T protein's m R N A with primers as used in another study (63) 
yielded a product of 292-bp, which is consistent with the published result. 
Normalizing the expression of m T E R T to that of L19 for each of the sample, yielded 
no significant differences in the expression of m T E R T in the spleens of the five 
groups of animals. While there was trend of positive correlation, i.e. corticosterone 
level in mice serum increases as m T E R T m R N A expression increases, this 
relationship was not statistically significant. 
4.8 Expression of mTERT protein 
Attempts were made to detect m T E R T by Western Blotting using an in-house 
antibody developed by a local research group (145), which detected an 85 kDa protein. 
However this is inconsistent with the published size of 127 kDa (160-162). Therefore 
this antibody was abandoned and a commercial antibody against m T E R T was 
subsequently used. The Western Blotting of m T E R T was done concurrently with that 
of histone protein, a house-keeping protein that acted as an internal control for each 
spleen extract. This resulted in a band with molecular weight of 120 kDa for m T E R T 
and 15 kDa for the histone protein. The intensity of the m T E R T protein band was 
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normalized to that of the corresponding histone protein band for comparison of results 
between various groups of animals. This was designed to control for the variations in 
amount of protein loaded in each sample. Despite the attempts to standardize the 
concentrations of the primary and secondary antibodies (the latter conjugated to HRP) 
and the substrate, the intensities of the bands obtained showed a marked variation 
between several runs of Western Blotting. Therefore, the relative m T E R T protein 
expression value obtained is perhaps not accurate for comparison of the telomerase 
between various groups of animals. Despite this set back, the assay results showed 
that the five groups of mice did not have significant differences in m T E R T protein 
expression in spleen tissue extracts. In other studies the expression of m T E R T protein 
correlates with telomerase activity in dividing mouse embryonic cells (162) and 
mouse adult tissues (64)，where telomerase activity were found to have positive 
correlation with m T E R T expression (64,162). Therefore, m T E R T expression level can 
be used as a supporting reference of telomerase activity. 
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4.9 Conclusion 
The regulation of telomeres probably involves many factors. This study was prompted 
by an observation in women perceived to be under psychological stress because of 
caring for sick children having shorter telomeres in their lymphocytes compared to 
women who were not under stress. Psychological stress may in turn activate bodily 
systems, such as the nervous, endocrine and immune systems -
psychoneuroimmunology mechanisms. One of these involves the activation of the 
H P A axis which leads to excessive secretion of glucocorticoids. Although Cortisol was 
not measured in women with shorter telomeres, the role of glucocorticoids was 
considered as one of the factors responsible for the phenomenon. (146, 155). To see if 
glucocorticoids were indeed involved, this study in Balb/c mice as a model was 
undertaken. The study was designed to see if different levels of corticosterone in mice 
had any impact on some of the parameters that are involved in the regulation of 
telomeres using spleen as the source of white blood cells. While some of the 
treatments administered to the animals were able to alter the corticosterone levels in 
some of the groups, however one essential group which was supposed to simulate a 
state of low glucocorticoids, proved unsuccessful because of the failure of 
adrenalectomy. Therefore it was unfortunate that data for a state without 
corticosterone is not available. The effect of prolonged elevation of serum 
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corticosterone level in mice due to chronic activation of HPA axis was simulated in 
this study. Balb/c mice were subjected to a suitable level of stress. Dexamethasone 
also effectively increases the catabolic activity in mice. The body weight, spleen 
weight and serum corticosterone concentration of mice showed that catabolic 
activities in stressed animals were boosted as a result of raising serum corticosterone 
level. Decrease in body weight, spleen weight and serum corticosterone concentration 
were observed in dexamethasone treated animals. Glucocorticoids were working in 
these animals' catabolism, as shown in other published literature (120). 
On the other hand, telomere length measurement, telomerase activity assay, m T E R T 
protein expression and its m R N A expression did not show any significant variation 
due to stress treatments. Correlations between telomere length or telomerase activity 
with corticosterone were not observed. This may be due too short treatment period, in 
which only the physiological activities occurs in acute stress were mimicked or that 
glucocorticoids have nothing to do with telomere length and telomerase activity 
regulations. Acute stress does not have prolonged and permanent effect in animals, as 
they restore homeostasis in acutely stressed animals. The treatment period should be 
extended in order to obtain more significant chronological effect. To extend the 
treatment period, dexamethasone dose should be lowered, as the body weight of 
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dexamethasone treated mice had obvious decreased in body weight. Also, spleen 
showed atrophy, which most likely was due to severe immunosuppressive effect of 
dexamethasone. While there are reports stating that dexamethasone decreases 
telomerase activity and telomere length before apoptosis in a relatively short period of 
time (146,155), the stated dose of dexamethasone administered i.e. lOOmg/lOg seems 
to be extremely excessive (146), and thus the results are questionable. 
In summary this study showed that glucocorticoids appeared to have no influence on 
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Figure 6.1 (a) Fluorescence profile of real-time PCR with protein sample from control 
mice spleen tissue. M1-M5: mouse number 1 to 5 in control group. Mean CT cycle = 
30.300 士 2.072 (n = 5). (b) Melt curve of real-time PCR product in which control 
mice spleen tissue protein was used. Each trace corresponds to one sample with the 
same colour in (a). Telomerase produces oligonucleotide products which have six 
base pair increments of telomeric repeats using TS substrate oligonucleotide as 
starting material. The products have melting points differ by about one degree Celsius 
for each 6-basepair elongation, thus a broad peak was observed. Significant peaks 
were observed at 78°C to 80°C. 
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Figure 6.1 (c) Real-time PCR fluorescence profile of heat-inactivated spleen protein 
sample from control mice. M1-M5: mouse number 1 to 5 in control group. Sample 
data of mouse two to four in this group were regarded as no activity, as their Q cycle 
> 35.2. Sample from mouse one does not have significant increase in fluorescence 
signal from baseline throughout real-time PCR, thus giving no CT cycle number, (d) 
Melt curve of real-time PCR product from heat-inactivated spleen protein sample 
from control mice. Each trace corresponds to one sample with the same colour in (c). 
Peaks at 78。C to 80。C were not significant compared with those in active sample (b). 
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Figure 6.1 (e) Fluorescence profile of real-time PCR with protein sample from 
stressed mice spleen tissue. M1-M5: mouse number 1 to 5 in stressed group (Ml: 
light blue, M4 : yellow). Mean CT cycle = 28.640 士 2.350 (n = 5). (f) Melt curve of 
real-time PCR product in which stressed mice spleen tissue protein was used. Each 
trace corresponds to one sample with the same colour in (e). Telomerase produces 
oligonucleotide products which have six base pair increments of telomeric repeats 
using TS substrate oligonucleotide as starting material. The products have melting 
points differ by about one degree Celsius for each 6-basepair elongation, thus a broad 
peak was observed. Significant peaks were observed at 78°C to 80。C. 
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Figure 6.1 (g) Real-time PGR fluorescence profile of heat-inactivated spleen protein 
sample from stressed mice. M1-M5: mouse number 1 to 5 in stressed group (M2: red, 
M3 : green). Sample of mouse one and five in this group were regarded as no activity, 
as their Ct cycle > 35.2. Sample of mouse four does not have significant increase in 
fluorescence signal from baseline throughout real-time PCR, thus giving no CT cycle 
number, (h) Melt curve of real-time PCR product from heat-inactivated spleen protein 
sample from stressed mice. Each trace corresponds to one sample with the same 
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Figure 6.1 (i) Fluorescence profile of real-time P C R with protein sample from vehicle 
treated mice spleen tissue. M l , M3-M5: mouse number one, three to five in vehicle 
treated group. Mean CT cycle = 29.700 士 1.311 (n = 3) (Mouse five data discarded) (j) 
Melt curve of real-time P C R product from heat-inactivated spleen protein sample 
from vehicle mice. Each trace corresponds to one sample with the same colour in (i). 
Telomerase produces oligonucleotide products which have six base pair increments of 
telomeric repeats using TS substrate oligonucleotide as starting material. The products 
have melting points differ by about one degree Celsius for each 6-basepair elongation, 
thus a broad peak was observed. Significant peaks were observed at 78。C to 80。C, 
except mouse five (green trace). 
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T e m p e r a t u r e , Celsius 
Figure 6.1 (k) Real-time PGR fluorescence profile of heat-inactivated spleen protein 
sample from vehicle treated mice. M l , M3-M5: mouse number one, three to five in 
vehicle treated group. Sample data from mouse one in this group were regarded as no 
activity, as their Ct cycle > 35.2. Spleen tissue sample of mouse five does not have 
significant increase in fluorescence signal from baseline throughout real-time PCR, 
thus giving no CT cycle number. (1) Melt curve of real-time PCR product from 
heat-inactivated spleen protein sample from vehicle treated mice. Each trace 
corresponds to one sample with the same colour in (k). Peaks at 78°C to 80°C were 
not significant compared with that in active sample (j)-
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T e m p e r a t u r e , C e l s i u s 
Figure 6.1 (m) Fluorescence profile of real-time P C R with protein sample from 
dexamethasone treated mice spleen tissue. M1-M5: mouse number one to five in 
dexamethasone treated group. Mean CT cycle = 30.9400 士 1.936 (n = 5) (n) Melt 
curve of real-time P C R product in which dexamethasone treated mice spleen tissue 
protein was used. Each trace corresponds to one sample with the same colour in (m). 
Telomerase produces oligonucleotide products which have six base pair increments of 
telomeric repeats using TS substrate oligonucleotide as starting material. The products 
have melting points differ by about one degree Celsius for each 6-basepair elongation, 
thus a broad peak was observed. Significant peaks were observed at 7 8 T to 80°C. 
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Figure 6.1 (o). Real-time P C R fluorescence profile of heat-inactivated spleen protein 
sample from dexamethasone treated mice. M1-M5: mouse number one to five in 
dexamethasone treated group (Ml: red, M4: brown, M5: purple). Sample data of 
mouse one, four and five in this group were regarded as no activity, as their Ct cycle > 
35.2. (p) Melt curve of real-time P C R product from heat-inactivated spleen protein 
sample from dexamethasone treated mice. Each trace corresponds to one sample with 
the same colour in (o). Peaks at 78°C to 80°C were not significant compared with that 
in active sample (n). 
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Figure 6.1 (q) Fluorescence profile of real-time PCR with protein sample from 
adrenalectomized mice spleen tissue. M1-M5: mouse number one to five in 
adrenalectomized group (M5: light blue, M 4 purple). Sample data of mouse two in 
this group was regarded as no activity, as their Ct cycle > 35.2. Mean C T cycle = 31.75 
士 1.987 (n = 4) (r) Melt curve of real-time PCR product in which adrenalectomized 
mice spleen tissue protein was used. Each trace corresponds to one sample with the 
same colour in (q). Telomerase produces oligonucleotide products which have six 
base pair increments of telomeric repeats using TS substrate oligonucleotide as 
starting material. The products have melting points differ by about one degree Celsius 
for each 6-basepair elongation, thus a broad peak was observed. Significant peaks 
were observed at 78®C to 80°C. 
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Figure 6.1 (s) Real-time P C R fluorescence profile of heat-inactivated spleen protein 
sample from adrenalectomized mice. M1-M5: mouse number one to five in 
adrenalectomized group (M5: red, M 3 ; brown, M2 : blue). Sample data from mouse 
two, three and five in this group were regarded as no activity, as their Ct cycle > 35.2. 
(t) Melt curve of real-time P C R product from heat-inactivated spleen protein sample 
from adrenalectomized mice. Each trace corresponds to one sample with the same 
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